false 04-30 2022 Q3 0000107140 0000107140 2021-05-01 2022-01-31 0000107140 jwa:ClassBCommonStockParValue100PerShareMember 2021-05-01 2022-01-31 0000107140 jwa:ClassACommonStockParValue100PerShareMember 2021-05-01 2022-01-31 0000107140 jwa:ClassBCommonStockParValue100PerShareMember 2022-02-28 0000107140 jwa:ClassACommonStockParValue100PerShareMember 2022-02-28 0000107140 2022-01-31 0000107140 2021-04-30 0000107140 us-gaap:CommonClassBMember 2022-01-31 0000107140 us-gaap:CommonClassAMember 2021-04-30 0000107140 us-gaap:CommonClassAMember 2022-01-31 0000107140 us-gaap:CommonClassBMember 2021-04-30 0000107140 2020-11-01 2021-01-31 0000107140 2021-11-01 2022-01-31 0000107140 2020-05-01 2021-01-31 0000107140 2020-04-30 0000107140 2021-01-31 0000107140 jwa:XYZMediaMember 2020-05-01 2021-01-31 0000107140 jwa:XYZMediaMember 2021-05-01 2022-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0000107140 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-04-30 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-31 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-10-31 0000107140 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-04-30 0000107140 us-gaap:RetainedEarningsMember 2020-04-30 0000107140 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonClassBMember 2020-04-30 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-04-30 0000107140 us-gaap:TreasuryStockMember 2020-10-31 0000107140 us-gaap:RetainedEarningsMember 2020-10-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-10-31 0000107140 2021-10-31 0000107140 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-10-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-30 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-04-30 0000107140 us-gaap:RetainedEarningsMember 2021-04-30 0000107140 2020-10-31 0000107140 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-04-30 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-10-31 0000107140 us-gaap:RetainedEarningsMember 2021-10-31 0000107140 us-gaap:TreasuryStockMember 2020-04-30 0000107140 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-04-30 0000107140 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-04-30 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-30 0000107140 us-gaap:TreasuryStockMember 2021-04-30 0000107140 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0000107140 us-gaap:TreasuryStockMember 2021-10-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-04-30 0000107140 us-gaap:TreasuryStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-04-30 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-01 2021-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-01 2021-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-11-01 2021-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 2022-01-31 0000107140 us-gaap:RetainedEarningsMember 2020-05-01 2021-01-31 0000107140 us-gaap:RetainedEarningsMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-05-01 2021-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-05-01 2022-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-11-01 2022-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-05-01 2022-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2021-01-31 0000107140 us-gaap:RetainedEarningsMember 2021-11-01 2022-01-31 0000107140 us-gaap:RetainedEarningsMember 2020-11-01 2021-01-31 0000107140 us-gaap:TreasuryStockMember 2020-05-01 2021-01-31 0000107140 us-gaap:TreasuryStockMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-05-01 2021-01-31 0000107140 us-gaap:TreasuryStockMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-11-01 2022-01-31 0000107140 us-gaap:TreasuryStockMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassBMember 2020-05-01 2021-01-31 0000107140 us-gaap:TreasuryStockMember us-gaap:CommonClassBMember 2020-05-01 2021-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:TreasuryStockMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassBMember 2020-11-01 2021-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember us-gaap:CommonClassAMember 2020-11-01 2021-01-31 0000107140 us-gaap:TreasuryStockMember us-gaap:CommonClassAMember 2021-11-01 2022-01-31 0000107140 us-gaap:TreasuryStockMember us-gaap:CommonClassBMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:RetainedEarningsMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassBMember 2021-05-01 2022-01-31 0000107140 us-gaap:RetainedEarningsMember us-gaap:CommonClassBMember 2021-11-01 2022-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:CommonClassBMember 2021-11-01 2022-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:CommonClassBMember 2020-05-01 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:RetainedEarningsMember 2020-11-01 2021-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember us-gaap:CommonClassBMember 2021-11-01 2022-01-31 0000107140 us-gaap:TreasuryStockMember us-gaap:CommonClassAMember 2020-05-01 2021-01-31 0000107140 us-gaap:RetainedEarningsMember us-gaap:CommonClassBMember 2020-11-01 2021-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:CommonClassAMember 2020-05-01 2021-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember us-gaap:CommonClassBMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 2022-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember us-gaap:CommonClassAMember 2020-05-01 2021-01-31 0000107140 us-gaap:CommonClassBMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:RetainedEarningsMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:TreasuryStockMember 2021-05-01 2022-01-31 0000107140 us-gaap:TreasuryStockMember us-gaap:CommonClassAMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:RetainedEarningsMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:AdditionalPaidInCapitalMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassAMember 2020-11-01 2021-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:TreasuryStockMember 2021-11-01 2022-01-31 0000107140 us-gaap:CommonClassAMember 2020-05-01 2021-01-31 0000107140 us-gaap:RetainedEarningsMember us-gaap:CommonClassBMember 2020-05-01 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:RetainedEarningsMember 2020-05-01 2021-01-31 0000107140 us-gaap:RetainedEarningsMember 2022-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-31 0000107140 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0000107140 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-31 0000107140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-31 0000107140 us-gaap:TreasuryStockMember 2021-01-31 0000107140 us-gaap:TreasuryStockMember 2022-01-31 0000107140 us-gaap:RetainedEarningsMember 2021-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-31 0000107140 us-gaap:AdditionalPaidInCapitalMember 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:XYZMediaMember 2021-12-29 2021-12-29 0000107140 jwa:HindawiMember 2020-12-31 2020-12-31 0000107140 jwa:OtherAcquistionsMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember jwa:XYZMediaMember 2021-12-29 2021-12-29 0000107140 jwa:XYZMediaMember 2021-11-01 2022-01-31 0000107140 jwa:XYZMediaMember 2021-05-01 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:HindawiMember 2021-11-01 2022-01-31 0000107140 jwa:XYZMediaMember jwa:EducationServicesSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember jwa:XYZMediaMember 2021-11-01 2022-01-31 0000107140 jwa:OtherAcquistionsMember 2021-11-01 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:HindawiMember 2021-05-01 2022-01-31 0000107140 jwa:OtherAcquistionsMember jwa:EducationServicesSegmentMember 2021-05-01 2021-07-31 0000107140 jwa:OtherAcquistionsMember jwa:ResearchPublishingAndPlatformsSegmentMember 2021-11-01 2022-01-31 0000107140 jwa:OtherAcquistionsMember 2022-01-31 0000107140 jwa:HindawiMember 2022-01-31 0000107140 jwa:XYZMediaMember 2021-12-29 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:OtherAcquistionsMember 2022-01-31 0000107140 jwa:HindawiMember jwa:ResearchPublishingAndPlatformsSegmentMember 2022-01-31 0000107140 jwa:OtherAcquistionsMember jwa:EducationServicesSegmentMember 2022-01-31 0000107140 jwa:XYZMediaMember srt:MinimumMember 2021-05-01 2022-01-31 0000107140 us-gaap:DevelopedTechnologyRightsMember jwa:OtherAcquistionsMember 2021-05-01 2022-01-31 0000107140 us-gaap:NoncompeteAgreementsMember jwa:OtherAcquistionsMember 2021-05-01 2022-01-31 0000107140 jwa:OtherAcquistionsMember us-gaap:CustomerRelationshipsMember 2021-05-01 2022-01-31 0000107140 jwa:OtherAcquistionsMember us-gaap:TrademarksMember 2021-05-01 2022-01-31 0000107140 srt:MaximumMember jwa:XYZMediaMember 2021-05-01 2022-01-31 0000107140 jwa:HindawiMember 2020-12-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:AcademicAndProfessionalLearningSegmentMember 2020-11-01 2021-01-31 0000107140 jwa:TalentDevelopmentServicesMember jwa:EducationServicesSegmentMember us-gaap:OperatingSegmentsMember 2021-11-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ResearchPublishingAndPlatformsSegmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ProfessionalLearningMember jwa:AcademicAndProfessionalLearningSegmentMember 2021-11-01 2022-01-31 0000107140 jwa:TalentDevelopmentServicesMember jwa:EducationServicesSegmentMember jwa:WileyNXTMember 2020-11-01 2021-01-31 0000107140 jwa:OnlineProgramManagementDeltakMember jwa:EducationServicesSegmentMember us-gaap:OperatingSegmentsMember 2021-05-01 2022-01-31 0000107140 jwa:ResearchPublishingMember jwa:ResearchPublishingAndPlatformsSegmentMember us-gaap:OperatingSegmentsMember 2020-11-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:AcademicAndProfessionalLearningSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember jwa:OnlineProgramManagementDeltakMember us-gaap:OperatingSegmentsMember 2021-11-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ProfessionalLearningMember jwa:AcademicAndProfessionalLearningSegmentMember 2020-11-01 2021-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember us-gaap:OperatingSegmentsMember jwa:ResearchPlatformsMember 2021-05-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ResearchPublishingAndPlatformsSegmentMember 2021-11-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember us-gaap:OperatingSegmentsMember jwa:OnlineProgramManagementDeltakMember 2020-05-01 2021-01-31 0000107140 jwa:EducationPublishingMember us-gaap:OperatingSegmentsMember jwa:AcademicAndProfessionalLearningSegmentMember 2020-05-01 2021-01-31 0000107140 jwa:EducationServicesSegmentMember jwa:TalentDevelopmentServicesMember us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:OnlineProgramManagementDeltakMember jwa:EducationServicesSegmentMember 2020-11-01 2021-01-31 0000107140 jwa:ResearchPlatformsMember us-gaap:OperatingSegmentsMember jwa:ResearchPublishingAndPlatformsSegmentMember 2020-11-01 2021-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:ResearchPublishingMember us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ResearchPlatformsMember jwa:ResearchPublishingAndPlatformsSegmentMember 2021-11-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:EducationServicesSegmentMember jwa:TalentDevelopmentServicesMember 2021-05-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:OperatingSegmentsMember 2021-11-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember us-gaap:OperatingSegmentsMember 2021-05-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:EducationPublishingMember jwa:AcademicAndProfessionalLearningSegmentMember 2021-11-01 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 jwa:WileyNXTMember jwa:EducationServicesSegmentMember jwa:TalentDevelopmentServicesMember 2020-05-01 2021-01-31 0000107140 jwa:EducationServicesSegmentMember us-gaap:OperatingSegmentsMember jwa:TalentDevelopmentServicesMember 2020-11-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:EducationServicesSegmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ProfessionalLearningMember jwa:AcademicAndProfessionalLearningSegmentMember 2020-05-01 2021-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember us-gaap:OperatingSegmentsMember jwa:ResearchPublishingMember 2021-11-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ResearchPublishingMember jwa:ResearchPublishingAndPlatformsSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:ResearchPlatformsMember us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ProfessionalLearningMember jwa:AcademicAndProfessionalLearningSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:OperatingSegmentsMember jwa:EducationPublishingMember 2021-05-01 2022-01-31 0000107140 jwa:EducationPublishingMember us-gaap:OperatingSegmentsMember jwa:AcademicAndProfessionalLearningSegmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:EducationServicesSegmentMember 2021-11-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember jwa:ResearchPublishingAndPlatformsSegmentMember 2021-05-01 2022-01-31 0000107140 us-gaap:RevenueFromContractWithCustomerMember us-gaap:TransferredAtPointInTimeMember jwa:ProfessionalLearningMember us-gaap:ProductConcentrationRiskMember jwa:ProfessionalPublishingAndLicensingAndOtherMember jwa:AcademicAndProfessionalLearningSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:ProfessionalLearningMember jwa:CorporateTrainingAndCorporateLearningMember jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember us-gaap:TransferredOverTimeMember 2021-05-01 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:JournalSubscriptionsOpenAccessAndComprehensiveAgreementsMember us-gaap:RevenueFromContractWithCustomerMember jwa:ResearchPublishingMember us-gaap:ProductConcentrationRiskMember 2021-11-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember jwa:EducationPublishingMember us-gaap:ProductConcentrationRiskMember us-gaap:TransferredOverTimeMember us-gaap:RevenueFromContractWithCustomerMember jwa:EducationPublishingPrintAndDigitalCoursewareMember 2021-05-01 2022-01-31 0000107140 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember jwa:EducationPublishingPrintAndDigitalCoursewareMember jwa:AcademicAndProfessionalLearningSegmentMember jwa:EducationPublishingMember us-gaap:TransferredOverTimeMember 2021-11-01 2022-01-31 0000107140 us-gaap:ProductConcentrationRiskMember jwa:ProfessionalLearningMember us-gaap:TransferredAtPointInTimeMember us-gaap:RevenueFromContractWithCustomerMember jwa:AcademicAndProfessionalLearningSegmentMember jwa:ProfessionalPublishingAndLicensingAndOtherMember 2021-11-01 2022-01-31 0000107140 jwa:EducationPublishingPrintAndDigitalMember jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:RevenueFromContractWithCustomerMember jwa:EducationPublishingMember us-gaap:ProductConcentrationRiskMember us-gaap:TransferredAtPointInTimeMember 2021-11-01 2022-01-31 0000107140 us-gaap:TransferredOverTimeMember jwa:CorporateTrainingAndCorporateLearningMember us-gaap:RevenueFromContractWithCustomerMember jwa:ProfessionalLearningMember jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:ProductConcentrationRiskMember 2021-11-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember us-gaap:ProductConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember jwa:EducationPublishingPrintAndDigitalMember jwa:EducationPublishingMember us-gaap:TransferredAtPointInTimeMember 2021-05-01 2022-01-31 0000107140 jwa:ResearchPublishingMember jwa:ResearchPublishingAndPlatformsSegmentMember us-gaap:ProductConcentrationRiskMember jwa:JournalSubscriptionsOpenAccessAndComprehensiveAgreementsMember us-gaap:RevenueFromContractWithCustomerMember 2021-05-01 2022-01-31 0000107140 2023-02-01 2022-01-31 0000107140 2022-02-01 2022-01-31 0000107140 us-gaap:ShippingAndHandlingMember 2020-11-01 2021-01-31 0000107140 us-gaap:ShippingAndHandlingMember 2020-05-01 2021-01-31 0000107140 us-gaap:ShippingAndHandlingMember 2021-05-01 2022-01-31 0000107140 us-gaap:ShippingAndHandlingMember 2021-11-01 2022-01-31 0000107140 us-gaap:PerformanceSharesMember 2021-05-01 2022-01-31 0000107140 us-gaap:RestrictedStockMember 2021-05-01 2022-01-31 0000107140 us-gaap:RestrictedStockMember 2020-05-01 2021-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2016-04-01 2021-10-31 0000107140 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember jwa:ShareBasedCompensationAwardTrancheFourMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2019-04-30 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-30 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2021-10-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-30 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-04-30 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-10-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-10-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-04-30 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-10-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2020-10-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-10-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-04-30 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-04-30 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-11-01 2021-01-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-05-01 2021-01-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2020-05-01 2021-01-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-05-01 2022-01-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-11-01 2021-01-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2021-05-01 2022-01-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-05-01 2021-01-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-11-01 2022-01-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2021-11-01 2022-01-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-11-01 2022-01-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-05-01 2022-01-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2022-01-31 0000107140 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-01-31 0000107140 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-31 0000107140 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-31 0000107140 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2021-11-01 2022-01-31 0000107140 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-11-01 2021-01-31 0000107140 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-05-01 2021-01-31 0000107140 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2020-11-01 2021-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2021-11-01 2022-01-31 0000107140 us-gaap:EmployeeStockOptionMember 2020-05-01 2021-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember jwa:BusinessOptimizationProgramMember 2020-05-01 2021-01-31 0000107140 us-gaap:OtherRestructuringMember jwa:BusinessOptimizationProgramMember 2020-05-01 2021-01-31 0000107140 us-gaap:CorporateMember jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 us-gaap:CorporateMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:EducationServicesSegmentMember 2020-05-01 2021-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:BusinessOptimizationProgramMember 2020-05-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:FacilityClosingMember 2020-11-01 2021-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:BusinessOptimizationProgramMember 2020-11-01 2021-01-31 0000107140 us-gaap:OtherRestructuringMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:FacilityClosingMember 2021-11-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:AccelerationOfExpenseRelatedToOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2020-05-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:AccelerationOfExpenseRelatedToOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:EmployeeSeveranceMember jwa:BusinessOptimizationProgramMember 2020-05-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember 2020-05-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:CorporateMember 2020-11-01 2021-01-31 0000107140 us-gaap:EmployeeSeveranceMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:ImpairmentOfOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2020-05-01 2021-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:AcademicAndProfessionalLearningSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember jwa:BusinessOptimizationProgramMember 2020-11-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:FacilityClosingMember 2021-05-01 2022-01-31 0000107140 jwa:AccelerationOfExpenseRelatedToOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 jwa:ImpairmentOfOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember jwa:BusinessOptimizationProgramMember 2021-05-01 2022-01-31 0000107140 us-gaap:EmployeeSeveranceMember jwa:BusinessOptimizationProgramMember 2020-11-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:OtherRestructuringMember 2020-11-01 2021-01-31 0000107140 us-gaap:FacilityClosingMember jwa:BusinessOptimizationProgramMember 2020-05-01 2021-01-31 0000107140 jwa:EducationServicesSegmentMember jwa:BusinessOptimizationProgramMember 2020-11-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:ImpairmentOfOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:EmployeeSeveranceMember jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 jwa:AccelerationOfExpenseRelatedToOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 us-gaap:OtherRestructuringMember jwa:BusinessOptimizationProgramMember 2021-11-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember 2020-11-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:CorporateMember 2020-05-01 2021-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:EducationServicesSegmentMember 2021-11-01 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:ImpairmentOfOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2021-11-01 2022-01-31 0000107140 us-gaap:EmployeeSeveranceMember jwa:BusinessOptimizationProgramMember 2022-01-31 0000107140 us-gaap:OtherRestructuringMember jwa:BusinessOptimizationProgramMember 2022-01-31 0000107140 us-gaap:CorporateMember jwa:BusinessOptimizationProgramMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:EducationServicesSegmentMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:FacilityClosingMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:ImpairmentOfOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:AccelerationOfExpenseRelatedToOperatingLeaseRightOfUseAssetsAndPropertyAndEquipmentMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember jwa:ResearchPublishingAndPlatformsSegmentMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember jwa:BusinessOptimizationProgramMember 2022-01-31 0000107140 jwa:BusinessOptimizationProgramMember 2021-04-30 0000107140 jwa:BusinessOptimizationProgramMember us-gaap:EmployeeSeveranceMember 2021-04-30 0000107140 jwa:EducationServicesSegmentMember jwa:WileyNXTMember 2020-11-01 2021-01-31 0000107140 jwa:EducationServicesSegmentMember jwa:WileyNXTMember 2020-05-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember 2021-05-01 2022-01-31 0000107140 us-gaap:CorporateNonSegmentMember 2020-11-01 2021-01-31 0000107140 us-gaap:CorporateNonSegmentMember 2020-05-01 2021-01-31 0000107140 us-gaap:CorporateNonSegmentMember 2021-05-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember 2021-11-01 2022-01-31 0000107140 us-gaap:CorporateNonSegmentMember 2021-11-01 2022-01-31 0000107140 us-gaap:OperatingSegmentsMember 2020-11-01 2021-01-31 0000107140 us-gaap:OperatingSegmentsMember 2020-05-01 2021-01-31 0000107140 jwa:EducationServicesSegmentMember 2021-04-30 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember 2021-04-30 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember 2021-04-30 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember 2021-05-01 2022-01-31 0000107140 jwa:EducationServicesSegmentMember 2022-01-31 0000107140 jwa:AcademicAndProfessionalLearningSegmentMember 2022-01-31 0000107140 jwa:ResearchPublishingAndPlatformsSegmentMember 2022-01-31 0000107140 us-gaap:ArtisticRelatedIntangibleAssetsMember 2022-01-31 0000107140 us-gaap:NoncompeteAgreementsMember 2022-01-31 0000107140 us-gaap:NoncompeteAgreementsMember 2021-04-30 0000107140 us-gaap:TrademarksAndTradeNamesMember 2021-04-30 0000107140 us-gaap:DevelopedTechnologyRightsMember 2021-04-30 0000107140 us-gaap:CustomerRelationshipsMember 2022-01-31 0000107140 us-gaap:CustomerRelationshipsMember 2021-04-30 0000107140 us-gaap:ArtisticRelatedIntangibleAssetsMember 2021-04-30 0000107140 us-gaap:TrademarksAndTradeNamesMember 2022-01-31 0000107140 us-gaap:DevelopedTechnologyRightsMember 2022-01-31 0000107140 us-gaap:TrademarksAndTradeNamesMember 2021-04-30 0000107140 us-gaap:ArtisticRelatedIntangibleAssetsMember 2022-01-31 0000107140 us-gaap:ArtisticRelatedIntangibleAssetsMember 2021-04-30 0000107140 us-gaap:TrademarksAndTradeNamesMember 2022-01-31 0000107140 us-gaap:HerMajestysRevenueAndCustomsHMRCMember srt:MinimumMember 2021-05-01 2022-01-31 0000107140 srt:MaximumMember us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2020-05-01 2021-01-31 0000107140 us-gaap:HerMajestysRevenueAndCustomsHMRCMember srt:MaximumMember 2021-05-01 2022-01-31 0000107140 us-gaap:HerMajestysRevenueAndCustomsHMRCMember srt:MinimumMember 2020-05-01 2021-01-31 0000107140 us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2021-05-01 2022-01-31 0000107140 us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2020-05-01 2021-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember jwa:TermLoanAFacilityMember 2022-01-31 0000107140 jwa:TermLoanAFacilityMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2021-04-30 0000107140 us-gaap:RevolvingCreditFacilityMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2022-01-31 0000107140 us-gaap:RevolvingCreditFacilityMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2021-04-30 0000107140 us-gaap:RevolvingCreditFacilityMember 2021-05-01 2022-01-31 0000107140 jwa:TermLoanAFacilityMember 2021-05-01 2022-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2021-05-01 2022-01-31 0000107140 us-gaap:RevolvingCreditFacilityMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2019-05-30 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember jwa:TermLoanAFacilityMember 2019-05-30 0000107140 us-gaap:BaseRateMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember srt:MaximumMember jwa:SyndicateBankGroupMember us-gaap:RevolvingCreditFacilityMember 2021-05-01 2022-01-31 0000107140 us-gaap:RevolvingCreditFacilityMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember jwa:SyndicateBankGroupMember srt:MinimumMember us-gaap:BaseRateMember 2021-05-01 2022-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember srt:MaximumMember jwa:SyndicateBankGroupMember us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-05-01 2022-01-31 0000107140 us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:RevolvingCreditFacilityMember jwa:SyndicateBankGroupMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember srt:MinimumMember 2021-05-01 2022-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember us-gaap:RevolvingCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember jwa:SyndicateBankGroupMember 2021-05-01 2022-01-31 0000107140 us-gaap:EurodollarMember jwa:SyndicateBankGroupMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2021-05-01 2022-01-31 0000107140 srt:MinimumMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember us-gaap:RevolvingCreditFacilityMember jwa:SyndicateBankGroupMember 2021-05-01 2022-01-31 0000107140 jwa:SyndicateBankGroupMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2021-05-01 2022-01-31 0000107140 us-gaap:RevolvingCreditFacilityMember jwa:SyndicateBankGroupMember jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2022-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2020-05-01 2021-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2021-11-01 2022-01-31 0000107140 jwa:AmendedAndRestatedRevolvingCreditAgreementMember 2020-11-01 2021-01-31 0000107140 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2022-01-31 0000107140 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2021-04-30 0000107140 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashFlowHedgingMember 2022-01-31 0000107140 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueInputsLevel2Member us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-31 0000107140 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2021-04-30 0000107140 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-31 0000107140 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentLiabilitiesMember 2022-01-31 0000107140 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember 2021-05-01 2022-01-31 0000107140 us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-11-01 2021-01-31 0000107140 us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-05-01 2021-01-31 0000107140 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember 2021-11-01 2022-01-31 0000107140 us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2021-01-31 0000107140 us-gaap:CommonClassAMember jwa:DividendDeclaredInCurrentYearQ3Member 2021-05-01 2022-01-31 0000107140 jwa:DividendDeclaredInCurrentYearQ2Member us-gaap:CommonClassBMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember jwa:DividendDeclaredInCurrentYearQ1Member 2021-05-01 2022-01-31 0000107140 jwa:DividendDeclaredInCurrentYearQ1Member us-gaap:CommonClassBMember 2021-05-01 2022-01-31 0000107140 jwa:DividendDeclaredInCurrentYearQ2Member us-gaap:CommonClassAMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassBMember jwa:DividendDeclaredInCurrentYearQ3Member 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassBMember jwa:DividendDeclaredInCurrentYearQ1Member 2021-07-21 2021-07-21 0000107140 us-gaap:CommonClassAMember jwa:DividendDeclaredInCurrentYearQ3Member 2022-01-12 2022-01-12 0000107140 us-gaap:CommonClassAMember jwa:DividendDeclaredInCurrentYearQ2Member 2021-10-27 2021-10-27 0000107140 us-gaap:CommonClassAMember jwa:DividendDeclaredInCurrentYearQ1Member 2021-07-21 2021-07-21 0000107140 us-gaap:CommonClassBMember jwa:DividendDeclaredInCurrentYearQ3Member 2022-01-12 2022-01-12 0000107140 jwa:DividendDeclaredInCurrentYearQ2Member us-gaap:CommonClassBMember 2021-10-27 2021-10-27 0000107140 us-gaap:CommonClassBMember 2020-04-30 0000107140 us-gaap:CommonClassAMember 2020-04-30 0000107140 us-gaap:CommonClassAMember 2021-01-31 0000107140 us-gaap:CommonClassBMember 2021-01-31 0000107140 us-gaap:CommonClassAMember jwa:NonPerformanceSharesMember 2020-05-01 2021-01-31 0000107140 us-gaap:PerformanceSharesMember us-gaap:CommonClassAMember 2021-05-01 2022-01-31 0000107140 us-gaap:CommonClassAMember us-gaap:PerformanceSharesMember 2020-05-01 2021-01-31 0000107140 us-gaap:CommonClassAMember jwa:NonPerformanceSharesMember 2021-05-01 2022-01-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares jwa:Business xbrli:pure jwa:Segment iso4217:EUR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2022
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from_____ to _____
Commission File No. 001-11507
JOHN WILEY & SONS, INC.
(Exact name of Registrant as specified in its charter)

New York |  | 13-5593032
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
111 River Street, Hoboken, New Jersey |  | 07030
(Address of principal executive offices) |  | Zip Code

| (201) 748-6000 |
| Registrant’s telephone number, including area code |

| Not Applicable |
Former name, former address and former fiscal year, if changed since last report

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
Class A Common Stock, par value $1.00 per share |  | JW.A |  | New York Stock Exchange
Class B Common Stock, par value $1.00 per share |  | JW.B |  | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ | Accelerated filer ☐
Non-accelerated filer ☐ | Smaller reporting company ☐
| Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares outstanding of each of the Registrant’s classes of common stock as of February 28, 2022 were:
Class A, par value $1.00 – 46,669,560
Class B, par value $1.00 – 9,040,462

JOHN WILEY & SONS, INC. AND SUBSIDIARIES
INDEX
PART I - FINANCIAL INFORMATION

Item 1. |  | Financial Statements |  |
|  | Condensed Consolidated Statements of Financial Position – Unaudited as of January 31, 2022 and as of April 30, 2021 |  | 5
|  | Condensed Consolidated Statements of Net Income – Unaudited for the three and nine months ended January 31, 2022 and 2021 |  | 6
|  | Condensed Consolidated Statements of Comprehensive Income – Unaudited for the three and nine months ended January 31, 2022 and 2021 |  | 7
|  | Condensed Consolidated Statements of Cash Flows – Unaudited for the nine months ended January 31, 2022 and 2021 |  | 8
|  | Condensed Consolidated Statements of Shareholders' Equity – Unaudited for the three and nine months ended January 31, 2022 and 2021 |  | 9
|  | Notes to Unaudited Condensed Consolidated Financial Statements |  |
|  | Note 1. Basis of Presentation |  | 11
|  | Note 2. Recent Accounting Standards |  | 12
|  | Note 3. Acquisitions |  | 13
|  | Note 4. Revenue Recognition, Contracts with Customers |  | 15
|  | Note 5. Operating Leases |  | 18
|  | Note 6. Stock-Based Compensation |  | 19
|  | Note 7. Accumulated Other Comprehensive Loss |  | 20
|  | Note 8. Reconciliation of Weighted Average Shares Outstanding |  | 21
|  | Note 9. Restructuring and Related Charges (Credits) |  | 22
|  | Note 10. Segment Information |  | 23
|  | Note 11. Inventories |  | 24
|  | Note 12. Goodwill and Intangible Assets |  | 24
|  | Note 13. Income Taxes |  | 25
|  | Note 14. Retirement Plans |  | 26
|  | Note 15. Debt and Available Credit Facilities |  | 26
|  | Note 16. Derivative Instruments and Hedging Activities |  | 27
|  | Note 17. Capital Stock and Changes in Capital Accounts |  | 28
|  | Note 18. Commitments and Contingencies |  | 29
Item 2. |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  | 30
Item 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 50
Item 4. |  | Controls and Procedures |  | 51
PART II - OTHER INFORMATION |  |
Item 1. |  | Legal Proceedings |  | 52
Item 1A. |  | Risk Factors |  | 52
Item 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 52
Item 6. |  | Exhibits |  | 53
SIGNATURES |  | 54

2
INDEX

Cautionary Notice Regarding Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:
This report contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 concerning our business, consolidated financial condition and results of operations. The Securities and Exchange Commission (SEC) encourages companies to disclose forward-looking information so that investors can better understand a company’s prospects and make informed investment decisions. Forward-looking statements are subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can be identified by such words as “anticipates,” “believes,” “plan,” “assumes,” “could,” “should,” “estimates,” “expects,” “intends,” “potential,” “seek,” “predict,” “may,” “will” and similar references to future periods. All statements other than statements of historical facts included in this report regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding our fiscal year 2022 outlook, the anticipated impact on the ability of our employees, contractors, customers and other business partners to perform our and their respective responsibilities and obligations relative to the conduct of our business in the future due to the coronavirus (COVID-19) outbreak, anticipated restructuring charges and savings, operations, performance, and financial condition. Reliance should not be placed on forward-looking statements, as actual results may differ materially from those described in any forward-looking statements. Any such forward-looking statements are based upon many assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond our control, and are subject to change based on many important factors. Such factors include, but are not limited to (i) the level of investment by Wiley in new technologies and products; (ii) subscriber renewal rates for our journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key retailers; (vi) the seasonal nature of our educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) our ability to protect our copyrights and other intellectual property worldwide; (ix) our ability to successfully integrate acquired operations and realize expected opportunities; (x) the ability to realize operating savings over time and in fiscal year 2022 in connection with our multiyear Business Optimization Program; (xi) the impact of COVID-19 on our operations, performance, and financial condition; and (xii) other factors detailed from time to time in our filings with the SEC. We undertake no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Please refer to Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K and as revised and updated by our Quarterly Reports in Form 10-Q for important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Non-GAAP Financial Measures:
We present financial information that conforms to Generally Accepted Accounting Principles in the United States of America (US GAAP). We also present financial information that does not conform to US GAAP, which we refer to as non-GAAP.
In this report, we may present the following non-GAAP performance measures:

| ● | Adjusted Earnings Per Share (Adjusted EPS);

| ● | Free Cash Flow less Product Development Spending;

| ● | Adjusted Contribution to Profit and margin;

| ● | Adjusted Income Before Taxes;

| ● | Adjusted Income Tax Provision;

| ● | Adjusted Effective Tax Rate;

| ● | EBITDA, Adjusted EBITDA and margin;

| ● | Organic revenue; and

| ● | Results on a constant currency basis.

3
INDEX

Management uses these non-GAAP performance measures as supplemental indicators of our operating performance and financial position as well as for internal reporting and forecasting purposes, when publicly providing our outlook, to evaluate our performance and calculate incentive compensation. We present these non-GAAP performance measures in addition to US GAAP financial results because we believe that these non-GAAP performance measures provide useful information to certain investors and financial analysts for operational trends and comparisons over time. The use of these non-GAAP performance measures may also provide a consistent basis to evaluate operating profitability and performance trends by excluding items that we do not consider to be controllable activities for this purpose.
The performance metric used by our chief operating decision maker to evaluate performance of our reportable segments is Adjusted Contribution to Profit. We present both Adjusted Contribution to Profit and Adjusted EBITDA for each of our reportable segments since we believe Adjusted EBITDA provides additional useful information to certain investors and financial analysts for operational trends and comparisons over time as it removes the impact of depreciation and amortization expense, as well as a consistent basis to evaluate operating profitability and comparing our financial performance to that of our peer companies and competitors.
For example:

| ● | Adjusted EPS, Adjusted Contribution to Profit, Adjusted Income Before Taxes, Adjusted Income Tax Provision, Adjusted Effective Tax Rate, Adjusted EBITDA, and organic revenue (excluding acquisitions) provide a more comparable basis to analyze operating results and earnings and are measures commonly used by shareholders to measure our performance.

| ● | Free Cash Flow less Product Development Spending helps assess our ability, over the long term, to create value for our shareholders as it represents cash available to repay debt, pay common stock dividends, and fund share repurchases and acquisitions.

| ● | Results on a constant currency basis removes distortion from the effects of foreign currency movements to provide better comparability of our business trends from period to period. We measure our performance excluding the impact of foreign currency (or at constant currency), which means that we apply the same foreign currency exchange rates for the current and equivalent prior period.

In addition, we have historically provided these or similar non-GAAP performance measures and understand that some investors and financial analysts find this information helpful in analyzing our operating margins and net income, and in comparing our financial performance to that of our peer companies and competitors. Based on interactions with investors, we also believe that our non-GAAP performance measures are regarded as useful to our investors as supplemental to our US GAAP financial results, and that there is no confusion regarding the adjustments or our operating performance to our investors due to the comprehensive nature of our disclosures. We have not provided our 2022 outlook for the most directly comparable US GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with US GAAP.
Non-GAAP performance measures do not have standardized meanings prescribed by US GAAP and therefore may not be comparable to the calculation of similar measures used by other companies and should not be viewed as alternatives to measures of financial results under US GAAP. The adjusted metrics have limitations as analytical tools, and should not be considered in isolation from, or as a substitute for, US GAAP information. It does not purport to represent any similarly titled US GAAP information and is not an indicator of our performance under US GAAP. Non-GAAP financial metrics that we present may not be comparable with similarly titled measures used by others. Investors are cautioned against placing undue reliance on these non-GAAP measures.
4
INDEX

PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
JOHN WILEY & SONS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION – UNAUDITED
In thousands

|  | January 31, 2022 |  |  | April 30, 2021 |
Assets: |  |  |  |  |  |
Current assets |  |  |  |  |  |
Cash and cash equivalents |  | $ | 109,444 |  |  | $ | 93,795 |
Accounts receivable, net of allowance for credit losses of $22.8 million and $21.5 million, respectively |  |  | 267,988 |  |  |  | 311,571 |
Inventories, net |  |  | 39,726 |  |  |  | 42,538 |
Prepaid expenses and other current assets |  |  | 74,412 |  |  |  | 78,393 |
Total current assets |  |  | 491,570 |  |  |  | 526,297 |
Product development assets, net |  |  | 44,350 |  |  |  | 49,517 |
Royalty advances, net |  |  | 36,523 |  |  |  | 39,582 |
Technology, property and equipment, net |  |  | 271,984 |  |  |  | 282,270 |
Intangible assets, net |  |  | 970,893 |  |  |  | 1,015,302 |
Goodwill |  |  | 1,325,964 |  |  |  | 1,304,340 |
Operating lease right-of-use assets |  |  | 118,155 |  |  |  | 121,430 |
Other non-current assets |  |  | 118,545 |  |  |  | 107,701 |
Total assets |  | $ | 3,377,984 |  |  | $ | 3,446,439 |
Liabilities and shareholders' equity: |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 76,743 |  |  | $ | 95,791 |
Accrued royalties |  |  | 141,304 |  |  |  | 78,582 |
Short-term portion of long-term debt |  |  | 15,625 |  |  |  | 12,500 |
Contract liabilities |  |  | 355,846 |  |  |  | 545,425 |
Accrued employment costs |  |  | 105,286 |  |  |  | 144,744 |
Accrued income taxes |  |  | 16,804 |  |  |  | 8,590 |
Short-term portion of operating lease liabilities |  |  | 21,598 |  |  |  | 22,440 |
Other accrued liabilities |  |  | 88,275 |  |  |  | 80,900 |
Total current liabilities |  |  | 821,481 |  |  |  | 988,972 |
Long-term debt |  |  | 902,045 |  |  |  | 809,088 |
Accrued pension liability |  |  | 115,860 |  |  |  | 146,247 |
Deferred income tax liabilities |  |  | 182,899 |  |  |  | 172,903 |
Operating lease liabilities |  |  | 139,587 |  |  |  | 145,832 |
Other long-term liabilities |  |  | 96,594 |  |  |  | 92,106 |
Total liabilities |  |  | 2,258,466 |  |  |  | 2,355,148 |
Shareholders’ equity |  |  |  |  |  |  |  |
Preferred stock, $1 par value per share: Authorized shares – 2 million, Issued shares - 0 |  |  | — |  |  |  | — |
Class A common stock, $1 par value per share: Authorized shares - 180 million, Issued shares - 70,218 and 70,208 as of January 31, 2022 and April 30, 2021, respectively |  |  | 70,218 |  |  |  | 70,208 |
Class B common stock, $1 par value per share: Authorized shares - 72 million, Issued shares - 12,964 and 12,974 as of January 31, 2022 and April 30, 2021, respectively |  |  | 12,964 |  |  |  | 12,974 |
Additional paid-in-capital |  |  | 457,165 |  |  |  | 444,358 |
Retained earnings |  |  | 1,897,321 |  |  |  | 1,850,058 |
Accumulated other comprehensive loss, net of tax |  |  | (507,439 | ) |  |  | (490,790 | )
Less treasury shares at cost (Class A – 23,549 and 23,419 as of January 31, 2022 and April 30, 2021, respectively; Class B – 3,924 and 3,922 as of January 31, 2022 and April 30, 2021, respectively) |  |  | (810,711 | ) |  |  | (795,517 | )
Total shareholders’ equity |  |  | 1,119,518 |  |  |  | 1,091,291 |
Total liabilities and shareholders' equity |  | $ | 3,377,984 |  |  | $ | 3,446,439 |

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
5
INDEX

JOHN WILEY & SONS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME – UNAUDITED
Dollars in thousands except per share information

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Revenue, net |  | $ | 515,884 |  |  | $ | 482,912 |  |  | $ | 1,537,275 |  |  | $ | 1,405,249 |
Costs and expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of sales |  |  | 172,916 |  |  |  | 157,636 |  |  |  | 513,654 |  |  |  | 457,298 |
Operating and administrative expenses |  |  | 275,475 |  |  |  | 251,242 |  |  |  | 800,254 |  |  |  | 735,778 |
Restructuring and related charges (credits) |  |  | 448 |  |  |  | 20,675 |  |  |  | (1,161 | ) |  |  | 24,813 |
Amortization of intangible assets |  |  | 21,056 |  |  |  | 19,032 |  |  |  | 63,683 |  |  |  | 53,089 |
Total costs and expenses |  |  | 469,895 |  |  |  | 448,585 |  |  |  | 1,376,430 |  |  |  | 1,270,978 |
Operating income |  |  | 45,989 |  |  |  | 34,327 |  |  |  | 160,845 |  |  |  | 134,271 |
Interest expense |  |  | (5,103 | ) |  |  | (4,853 | ) |  |  | (14,739 | ) |  |  | (13,928 | )
Foreign exchange transaction losses |  |  | (488 | ) |  |  | (5,694 | ) |  |  | (1,488 | ) |  |  | (6,473 | )
Gain on sale of certain assets |  |  | — |  |  |  | — |  |  |  | 3,694 |  |  |  | — |
Other income, net |  |  | 2,821 |  |  |  | 3,612 |  |  |  | 9,524 |  |  |  | 11,769 |
Income before taxes |  |  | 43,219 |  |  |  | 27,392 |  |  |  | 157,836 |  |  |  | 125,639 |
Provision for income taxes |  |  | 7,853 |  |  |  | 5,231 |  |  |  | 52,673 |  |  |  | 18,712 |
Net income |  | $ | 35,366 |  |  | $ | 22,161 |  |  | $ | 105,163 |  |  | $ | 106,927 |
Earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.63 |  |  | $ | 0.40 |  |  | $ | 1.89 |  |  | $ | 1.91 |
Diluted |  | $ | 0.63 |  |  | $ | 0.39 |  |  | $ | 1.86 |  |  | $ | 1.90 |
Weighted average number of common shares outstanding: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 55,701 |  |  |  | 55,984 |  |  |  | 55,789 |  |  |  | 55,967 |
Diluted |  |  | 56,389 |  |  |  | 56,332 |  |  |  | 56,481 |  |  |  | 56,230 |

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
6
INDEX

JOHN WILEY & SONS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME – UNAUDITED
Dollars in thousands

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Net income |  | $ | 35,366 |  |  | $ | 22,161 |  |  | $ | 105,163 |  |  | $ | 106,927 |
Other comprehensive (loss) income: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  | (15,918 | ) |  |  | 48,305 |  |  |  | (31,338 | ) |  |  | 83,532 |
Unamortized retirement credits (costs), net of tax (expense) benefit of $(1,328), $1,912, $(2,954), and $2,621, respectively |  |  | 4,688 |  |  |  | (6,774 | ) |  |  | 10,342 |  |  |  | (9,036 | )
Unrealized gain on interest rate swaps, net of tax (expense) of $(678), $(184), $(1,453) and $(436), respectively |  |  | 2,000 |  |  |  | 582 |  |  |  | 4,347 |  |  |  | 1,472 |
Total other comprehensive (loss) income |  |  | (9,230 | ) |  |  | 42,113 |  |  |  | (16,649 | ) |  |  | 75,968 |
Comprehensive income |  | $ | 26,136 |  |  | $ | 64,274 |  |  | $ | 88,514 |  |  | $ | 182,895 |

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
7
INDEX

JOHN WILEY & SONS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS – UNAUDITED
Dollars in thousands

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Operating activities |  |  |  |  |  |
Net income |  | $ | 105,163 |  |  | $ | 106,927 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |  |  |
Amortization of intangible assets |  |  | 63,683 |  |  |  | 53,089 |
Amortization of product development assets |  |  | 26,662 |  |  |  | 25,323 |
Depreciation and amortization of technology, property and equipment |  |  | 72,139 |  |  |  | 68,841 |
Restructuring and related (credits) charges |  |  | (1,161 | ) |  |  | 24,813 |
Stock-based compensation expense |  |  | 19,361 |  |  |  | 14,744 |
Employee retirement plan expense |  |  | 14,309 |  |  |  | 9,080 |
Foreign exchange transaction losses |  |  | 1,488 |  |  |  | 6,473 |
Gain on sale of certain assets |  |  | (3,694 | ) |  |  | — |
Other noncash charges |  |  | 39,044 |  |  |  | 29,256 |
Net change in operating assets and liabilities |  |  | (178,510 | ) |  |  | (183,720 | )
Net cash provided by operating activities |  |  | 158,484 |  |  |  | 154,826 |
Investing activities |  |  |  |  |  |  |  |
Product development spending |  |  | (20,388 | ) |  |  | (17,103 | )
Additions to technology, property and equipment |  |  | (60,668 | ) |  |  | (58,176 | )
Businesses acquired in purchase transactions, net of cash acquired |  |  | (70,620 | ) |  |  | (298,590 | )
Proceeds related to the sale of certain assets |  |  | 3,375 |  |  |  | — |
Acquisitions of publication rights and other |  |  | (3,750 | ) |  |  | (18,524 | )
Net cash used in investing activities |  |  | (152,051 | ) |  |  | (392,393 | )
Financing activities |  |  |  |  |  |  |  |
Repayments of long-term debt |  |  | (268,466 | ) |  |  | (452,927 | )
Borrowings of long-term debt |  |  | 373,800 |  |  |  | 627,097 |
Purchases of treasury shares |  |  | (24,867 | ) |  |  | (7,063 | )
Change in book overdrafts |  |  | (4,000 | ) |  |  | 7,929 |
Cash dividends |  |  | (57,900 | ) |  |  | (57,802 | )
Impact of tax withholding on stock-based compensation and other |  |  | (5,468 | ) |  |  | (1,391 | )
Net cash provided by financing activities |  |  | 13,099 |  |  |  | 115,843 |
Effects of exchange rate changes on cash, cash equivalents, and restricted cash |  |  | (3,875 | ) |  |  | 10,631 |
Cash reconciliation: |  |  |  |  |  |  |  |
Cash and cash equivalents |  |  | 93,795 |  |  |  | 202,464 |
Restricted cash included in Prepaid expenses and other current assets |  |  | 564 |  |  |  | 583 |
Balance at beginning of period |  |  | 94,359 |  |  |  | 203,047 |
Increase/(decrease) for the period |  |  | 15,657 |  |  |  | (111,093 | )
Cash and cash equivalents |  |  | 109,444 |  |  |  | 91,321 |
Restricted cash included in Prepaid expenses and other current assets |  |  | 572 |  |  |  | 633 |
Balance at end of period |  | $ | 110,016 |  |  | $ | 91,954 |
Cash paid during the period for: |  |  |  |  |  |  |  |
Interest |  | $ | 13,601 |  |  | $ | 12,697 |
Income taxes, net of refunds |  | $ | 34,040 |  |  | $ | 46,148 |
Noncash items: |  |  |  |  |  |  |  |
Shares issued in connection with the acquisition of a business |  | $ | 7,363 |  |  | $ | — |

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
8
INDEX

JOHN WILEY & SONS, INC., AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY – UNAUDITED
Dollars in thousands

|  | Class A common stock |  |  | Class B common stock |  |  | Additional paid-in capital |  |  | Retained earnings |  |  | Accumulated other comprehensive loss, net of tax |  |  | Treasury stock |  |  | Total shareholders' equity |
Balance at October 31, 2021 |  | $ | 70,211 |  |  | $ | 12,971 |  |  | $ | 451,808 |  |  | $ | 1,881,235 |  |  | $ | (498,209 | ) |  | $ | (811,351 | ) |  | $ | 1,106,665 |
Restricted shares issued under stock-based compensation plans |  |  | — |  |  |  | — |  |  |  | (944 | ) |  |  | 1 |  |  |  | — |  |  |  | 1,015 |  |  |  | 72 |
Issuance of Class A common stock related to the acquisition of a business |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 7,363 |  |  |  | 7,363 |
Impact of tax withholding on stock-based compensation and other |  |  | — |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | (238 | ) |  |  | (236 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 6,299 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 6,299 |
Purchases of treasury shares |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7,500 | ) |  |  | (7,500 | )
Class A common stock dividends ($0.3450 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (16,162 | ) |  |  | — |  |  |  | — |  |  |  | (16,162 | )
Class B common stock dividends ($0.3450 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (3,119 | ) |  |  | — |  |  |  | — |  |  |  | (3,119 | )
Common stock class conversions |  |  | 7 |  |  |  | (7 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Comprehensive income, net of tax |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 35,366 |  |  |  | (9,230 | ) |  |  | — |  |  |  | 26,136 |
Balance at January 31, 2022 |  | $ | 70,218 |  |  | $ | 12,964 |  |  | $ | 457,165 |  |  | $ | 1,897,321 |  |  | $ | (507,439 | ) |  | $ | (810,711 | ) |  | $ | 1,119,518 |

|  | Class A common stock |  |  | Class B common stock |  |  | Additional paid-in capital |  |  | Retained earnings |  |  | Accumulated other comprehensive loss, net of tax |  |  | Treasury stock |  |  | Total shareholders' equity |
Balance at October 31, 2020 |  | $ | 70,179 |  |  | $ | 13,003 |  |  | $ | 435,851 |  |  | $ | 1,825,025 |  |  | $ | (541,642 | ) |  | $ | (782,203 | ) |  | $ | 1,020,213 |
Restricted shares issued under stock-based compensation plans |  |  | — |  |  |  | — |  |  |  | (128 | ) |  |  | 2 |  |  |  | — |  |  |  | 193 |  |  |  | 67 |
Impact of tax withholding on stock-based compensation and other |  |  | — |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | (47 | ) |  |  | (45 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 5,678 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5,678 |
Purchases of treasury shares |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7,063 | ) |  |  | (7,063 | )
Class A common stock dividends ($0.3425 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (16,220 | ) |  |  | — |  |  |  | — |  |  |  | (16,220 | )
Class B common stock dividends ($0.3425 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (3,102 | ) |  |  | — |  |  |  | — |  |  |  | (3,102 | )
Common stock class conversions |  |  | 29 |  |  |  | (29 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Comprehensive income, net of tax |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 22,161 |  |  |  | 42,113 |  |  |  | — |  |  |  | 64,274 |
Balance at January 31, 2021 |  | $ | 70,208 |  |  | $ | 12,974 |  |  | $ | 441,403 |  |  | $ | 1,827,866 |  |  | $ | (499,529 | ) |  | $ | (789,120 | ) |  | $ | 1,063,802 |

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
9
INDEX

JOHN WILEY & SONS, INC., AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY – UNAUDITED
Dollars in thousands

|  | Class A common stock |  |  | Class B common stock |  |  | Additional paid-in capital |  |  | Retained earnings |  |  | Accumulated other comprehensive loss, net of tax |  |  | Treasury stock |  |  | Total shareholders' equity |
Balance at April 30, 2021 |  | $ | 70,208 |  |  | $ | 12,974 |  |  | $ | 444,358 |  |  | $ | 1,850,058 |  |  | $ | (490,790 | ) |  | $ | (795,517 | ) |  | $ | 1,091,291 |
Restricted shares issued under stock-based compensation plans |  |  | — |  |  |  | — |  |  |  | (7,920 | ) |  |  | — |  |  |  | — |  |  |  | 8,129 |  |  |  | 209 |
Issuance of Class A common stock related to the acquisition of a business |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 7,363 |  |  |  | 7,363 |
Impact of tax withholding on stock-based compensation and other |  |  | — |  |  |  | — |  |  |  | 351 |  |  |  | — |  |  |  | — |  |  |  | (5,819 | ) |  |  | (5,468 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 20,376 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 20,376 |
Purchases of treasury shares |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (24,867 | ) |  |  | (24,867 | )
Class A common stock dividends ($0.3450 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (48,537 | ) |  |  | — |  |  |  | — |  |  |  | (48,537 | )
Class B common stock dividends ($0.3450 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (9,363 | ) |  |  | — |  |  |  | — |  |  |  | (9,363 | )
Common stock class conversions |  |  | 10 |  |  |  | (10 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Comprehensive income, net of tax |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 105,163 |  |  |  | (16,649 | ) |  |  | — |  |  |  | 88,514 |
Balance at January 31, 2022 |  | $ | 70,218 |  |  | $ | 12,964 |  |  | $ | 457,165 |  |  | $ | 1,897,321 |  |  | $ | (507,439 | ) |  | $ | (810,711 | ) |  | $ | 1,119,518 |

|  | Class A common stock |  |  | Class B common stock |  |  | Additional paid-in capital |  |  | Retained earnings |  |  | Accumulated other comprehensive loss, net of tax |  |  | Treasury stock |  |  | Total shareholders' equity |
Balance at April 30, 2020 |  | $ | 70,166 |  |  | $ | 13,016 |  |  | $ | 431,680 |  |  | $ | 1,780,129 |  |  | $ | (575,497 | ) |  | $ | (785,870 | ) |  | $ | 933,624 |
Cumulative effect of change in accounting principle, net of tax |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1,390 | ) |  |  | — |  |  |  | — |  |  |  | (1,390 | )
Restricted shares issued under stock-based compensation plans |  |  | — |  |  |  | — |  |  |  | (5,392 | ) |  |  | 2 |  |  |  | — |  |  |  | 5,575 |  |  |  | 185 |
Impact of tax withholding on stock-based compensation and other |  |  | — |  |  |  | — |  |  |  | 371 |  |  |  | — |  |  |  | — |  |  |  | (1,762 | ) |  |  | (1,391 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 14,744 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 14,744 |
Purchases of treasury shares |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7,063 | ) |  |  | (7,063 | )
Class A common stock dividends ($0.3425 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (48,477 | ) |  |  | — |  |  |  | — |  |  |  | (48,477 | )
Class B common stock dividends ($0.3425 per share) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (9,325 | ) |  |  | — |  |  |  | — |  |  |  | (9,325 | )
Common stock class conversions |  |  | 42 |  |  |  | (42 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Comprehensive income, net of tax |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 106,927 |  |  |  | 75,968 |  |  |  | — |  |  |  | 182,895 |
Balance at January 31, 2021 |  | $ | 70,208 |  |  | $ | 12,974 |  |  | $ | 441,403 |  |  | $ | 1,827,866 |  |  | $ | (499,529 | ) |  | $ | (789,120 | ) |  | $ | 1,063,802 |

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.
10
INDEX

JOHN WILEY & SONS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 — Basis of Presentation
Throughout this report, when we refer to “Wiley,” the “Company,” “we,” “our,” or “us,” we are referring to John Wiley & Sons, Inc. and all our subsidiaries, except where the context indicates otherwise.
Our Unaudited Condensed Consolidated Financial Statements include all the accounts of the Company and our subsidiaries. We have eliminated all intercompany transactions and balances in consolidation. In the opinion of management, the accompanying Unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the Unaudited Condensed Consolidated Financial Condition, Results of Operations, Comprehensive Income and Cash Flows for the periods presented. Operating results for the interim period are not necessarily indicative of the results expected for the full year. All amounts are in thousands, except per share amounts, and approximate due to rounding. These financial statements should be read in conjunction with the most recent audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 as filed with the SEC on July 6, 2021 (2021 Form 10-K).
Our Unaudited Condensed Consolidated Financial Statements were prepared in accordance with the interim reporting requirements of the SEC. As permitted under those rules, annual footnotes or other financial information that are normally required by US GAAP have been condensed or omitted. The preparation of our Unaudited Condensed Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year’s presentation.
In the fourth quarter of fiscal year 2021, a UK entity acquired in connection with the acquisition of mthree, which was acquired on January 1, 2020, was erroneously dissolved by the Company in accordance with UK Companies Act regulations while still holding assets. This entity, along with its subsidiaries, (the Entity) had various net intercompany receivables owed to them from other Wiley companies of approximately $188.8 million as of April 30, 2021 (approximately $122.4 million as of January 31, 2022), which upon a dissolution technically revert to the British Crown (Crown). Wiley petitioned to Companies House to reinstate the Entity without prejudice, which was completed in March 2022.
As a result of these events, the Company evaluated whether it was appropriate to consolidate the assets, liabilities, and operations of the Entity as part of its consolidated financial statements as of January 31, 2022 and April 30, 2021, and for the period from the Entity being dissolved through January 31, 2022. The Company has evaluated whether there was a liability to the Crown and a related loss associated with the dissolution of the Entity under US GAAP in fiscal year 2021 and as of January 31, 2022.
The Company evaluated the criteria in Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 810, “Consolidations” to determine if consolidating the Entity was appropriate under US GAAP. Based on that evaluation and the administrative nature of the process to restore, the Company concluded that although the Entity was dissolved, we maintained control of the assets of the Entity and, therefore, appropriately consolidated the assets, liabilities and operations of the Entity in our consolidated financial statements as of January 31, 2022 and April 30, 2021.
11
INDEX

Note 2 — Recent Accounting Standards
Recently Adopted Accounting Standards
Reference Rate Reform
In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01, “Reference Rate Reform: Scope.” These ASUs provide optional guidance for a limited period of time to ease the burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. This would apply to companies meeting certain criteria that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This standard is effective for us immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. On December 22, 2021, we amended the Amended and Restated RCA to change the rates for Sterling and Euro denominated borrowings from LIBOR-based rates to alternative rates. We applied ASU 2020-04 at the time of this modification, and there was no impact on our consolidated financial statements. Refer to Note 15, “Debt and Available Credit Facilities,” for more information. The future impact of this ASU on our consolidated financial statements will be based on any future contract modifications.
Simplifying the Accounting for Income Taxes
In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU is intended to simplify various aspects related to accounting for income taxes, eliminates certain exceptions within Topic 740, “Income Taxes” and clarifies certain aspects of the current guidance to promote consistent application. We adopted ASU 2019-12 on May 1, 2021. The adoption did not have a material impact on our consolidated financial statements at the time of adoption. The impact in the future would depend on any changes in tax laws and the applicable enactment dates. In accordance with ASU 2019-12, the enactment date is when any effects are recognized in the consolidated financial statements.
Recently Issued Accounting Standards
Accounting for Contract Assets and Contract Liabilities from Contracts with Customers
In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”. This ASU requires that an acquirer recognize, and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606 “Revenue from Contracts with Customers” (Topic 606) as if it had originated the contracts. Generally, this would result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements if the acquiree prepared financial statements in accordance with US GAAP. This standard is effective for us on May 1, 2023, including interim periods within the fiscal year. Early adoption is permitted. The standard is applied prospectively to business combinations occurring on or after the effective date of the amendments. The impact will be based on future business combinations after we adopt the standard.
Convertible Debt Instruments, Derivatives and EPS
In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)”. This ASU reduces the number of accounting models for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves and amends the related earnings-per-share (EPS) guidance. This standard is effective for us on May 1, 2022, including interim periods within the fiscal year. Adoption is either a modified retrospective method or a fully retrospective method of transition. We are currently assessing the impact the new guidance will have on our consolidated financial statements.
12
INDEX

Note 3 — Acquisitions
Pro forma financial information related to these acquisitions has not been provided as it is not material to our consolidated results of operations.
Fiscal Year 2022
XYZ Media
On December 29, 2021, we completed the acquisition of certain assets of XYZ Media Inc. (XYZ Media). XYZ Media is a company that generates leads for higher education institutions. The results of XYZ Media are included in our Education Services segment results. The fair value of consideration transferred at the date of acquisition was $45.4 million which included $38.0 million of cash, and approximately 129 thousand shares of Wiley Class A common stock, or approximately $7.4 million. We financed the payment of the cash consideration with a combination of cash on hand and borrowings under our Amended and Restated RCA (as defined below in Note 15, “Debt and Available Credit Facilities”).
The XYZ Media acquisition was accounted for using the acquisition method of accounting. The preliminary excess purchase price over identifiable net tangible and intangible assets acquired, and liabilities assumed has been recorded to Goodwill in our Condensed Consolidated Statements of Financial Position. Goodwill represents synergies and economies of scale expected from the combination of services. We recorded the preliminary fair value of the assets acquired and liabilities assumed on the acquisition date, which included a preliminary allocation of $21.6 million of goodwill and $23.3 million of intangible assets consisting of developed technology, customer relationships, covenants not to compete and trademarks that are being amortized over preliminary estimated weighted average useful lives ranging from 1 to 7 years. The goodwill will be deductible for tax purposes. The acquisition related costs to acquire XYZ Media were expensed when incurred and were approximately $0.1 million for both the three and nine months ended January 31, 2022. Such costs were allocated to the Education Services segment and are reflected in Operating and administrative expenses on the Condensed Consolidated Statements of Net Income for the three and nine months ended January 31, 2022.
XYZ Media’s revenue and operating loss included in our Education Services segment results for both the three and nine months ended January 31, 2022 was $1.0 million and $(0.3) million, respectively.
The allocation of the total consideration transferred to the assets acquired, including intangible assets and goodwill, and the liabilities assumed is preliminary, and could be revised as a result of additional information obtained due to the finalization of the third-party valuation report, leases and related commitments, tax related matters and contingencies and certain assets and liabilities, including receivables and payables, but such amounts will be finalized within the measurement period, which will not exceed one year from the acquisition date.
Other Acquisitions in Fiscal Year 2022
On November 30, 2021, we acquired the assets of the eJournalPress business (EJP) from Precision Computer Works, Inc. EJP is a technology platform company with an established journal submission and peer review management system. The results of EJP are included in our Research Publishing & Platforms segment results.
On October 1, 2021, we completed the acquisition of certain assets of J&J Editorial Services, LLC. (J&J). J&J is a publishing services company providing expert offerings in editorial operations, production, copyediting, system support and consulting. The results of J&J are included in our Research Publishing & Platforms segment results.
We also completed in the three months ended January 31, 2022, the acquisition of one immaterial business included in our Research Publishing & Platforms segment, and in the three months ended July 31, 2021, the acquisition of one immaterial business in our Education Services segment.
The aggregate preliminary fair value of consideration transferred for these other acquisitions was approximately $38.3 million during the nine months ended January 31, 2022 which included $33.7 million of cash paid at the acquisition dates and $4.6 million of additional cash to be paid after the acquisition dates. The fair value of the cash consideration transferred, net of $1.2 million of cash acquired was approximately $32.5 million. These other acquisitions were accounted for using the acquisition method of accounting as of their respective acquisition dates.
13
INDEX

Associated with these other acquisitions, the preliminary aggregate excess purchase price over identifiable net tangible and intangible assets acquired, and liabilities assumed of $21.3 million has been recorded to Goodwill on our Condensed Consolidated Statements of Financial Position as of January 31, 2022 and $13.6 million of intangible assets subject to amortization have been recorded, including developed technology, customer relationships, trademarks, and covenants not to compete that are being amortized over preliminary estimated weighted average useful lives of 5, 9, 2, and 4 years, respectively. The fair value assessed for the majority of the tangible assets acquired and liabilities assumed approximated their carrying value. Goodwill represents synergies and economies of scale expected from the combination of services. Goodwill of $21.3 million has been allocated to the Research Publishing & Platforms segment and none has been allocated to the Education Services segment. Approximately $17.8 million of the goodwill will be deductible for tax purposes, and $3.5 million will not be deductible for tax purposes. The incremental revenue for the three and nine months ended January 31, 2022 related to these other acquisitions was approximately $2.8 million and $3.5, respectively. The aggregate acquisition related costs to acquire these other acquisitions was expensed when incurred and was approximately $0.4 million for the nine months ended January 31, 2022.
The allocation of the total consideration transferred to the assets acquired, including intangible assets and goodwill, and the liabilities assumed is preliminary, and could be revised as a result of additional information obtained due to the finalization of the third-party valuation report, leases and related commitments, tax related matters and contingencies and certain assets and liabilities, including receivables and payables, but such amounts will be finalized within the measurement period, which will not exceed one year from the acquisition date.
Fiscal Year 2021
On December 31, 2020, we completed the acquisition of 100% of the outstanding stock of Hindawi Limited (“Hindawi”). Hindawi is a scientific research publisher and an innovator in open access publishing. Its results of operations are included in our Research Publishing & Platforms segment.
The fair value of the consideration transferred at the acquisition date was $300.1 million which included $299.3 million of cash and $0.8 million related to the settlement of a preexisting relationship. We financed the payment of the cash consideration primarily through borrowings under our Amended and Restated RCA (as defined below in Note 15, “Debt and Available Credit Facilities”) and using cash on hand. The fair value of the cash consideration transferred, net of $1.0 million of cash acquired was approximately $298.3 million.
Hindawi’s revenue and operating income included in our Research Publishing & Platforms segment results for the three months ended January 31, 2022 was $15.2 million and $3.5 million, respectively. Hindawi’s revenue and operating income included in our Research Publishing & Platforms segment results for the nine months ended January 31, 2022 was $39.8 million and $8.6 million, respectively.
During the nine months ended January 31, 2022, no revisions were made to the allocation of the consideration transferred to the assets acquired and liabilities assumed. We recorded the fair value of the assets acquired and liabilities assumed on the acquisition date, which included an allocation of $147.4 million of goodwill allocated to the Research Publishing & Platforms segment, and $194.9 million of intangible assets subject to amortization.
The allocation of the consideration transferred to the assets acquired and the liabilities assumed was finalized during the three months ended January 31, 2022.
14
INDEX

Note 4 — Revenue Recognition, Contracts with Customers
Disaggregation of Revenue
The following table presents our revenue from contracts with customers disaggregated by segment and product type.

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Research Publishing & Platforms: |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing |  | $ | 248,884 |  |  | $ | 229,327 |  |  | $ | 775,115 |  |  | $ | 700,482 |
Research Platforms |  |  | 14,457 |  |  |  | 10,523 |  |  |  | 38,136 |  |  |  | 31,512 |
Total Research Publishing & Platforms |  |  | 263,341 |  |  |  | 239,850 |  |  |  | 813,251 |  |  |  | 731,994 |
Academic & Professional Learning: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Education Publishing (1) |  |  | 95,498 |  |  |  | 97,671 |  |  |  | 260,459 |  |  |  | 263,702 |
Professional Learning |  |  | 75,135 |  |  |  | 75,955 |  |  |  | 225,967 |  |  |  | 206,269 |
Total Academic & Professional Learning |  |  | 170,633 |  |  |  | 173,626 |  |  |  | 486,426 |  |  |  | 469,971 |
Education Services: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
University Services (2) |  |  | 55,090 |  |  |  | 56,725 |  |  |  | 167,565 |  |  |  | 163,248 |
Talent Development Services (1)(3) |  |  | 26,820 |  |  |  | 12,711 |  |  |  | 70,033 |  |  |  | 40,036 |
Total Education Services |  |  | 81,910 |  |  |  | 69,436 |  |  |  | 237,598 |  |  |  | 203,284 |
Total Revenue |  | $ | 515,884 |  |  | $ | 482,912 |  |  | $ | 1,537,275 |  |  | $ | 1,405,249 |

(1) | In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services – Talent Development Services. The revenue was $0.5 million and $1.6 million for the three and nine months ended January 31, 2021, respectively. There were no changes to our total consolidated financial results.

(2) | University Services was previously referred to as Education Services OPM.

(3) | Talent Development Services was previously referred to as mthree.

The following information describes our disaggregation of revenue by segment and product type. Overall, the majority of our revenue is recognized over time.
Research Publishing & Platforms
Research Publishing & Platforms customers include academic, corporate, government, and public libraries, funders of research, researchers, scientists, clinicians, engineers and technologists, scholarly and professional societies, and students and professors. Research Publishing & Platforms products are sold and distributed globally through multiple channels, including research libraries and library consortia, independent subscription agents, direct sales to professional society members, and other customers. Publishing centers include Australia, China, Germany, India, the United Kingdom (UK), and the United States (US). The majority of revenue generated from Research Publishing & Platforms products is recognized over time. Total Research Publishing & Platforms revenue was $263.3 million and $813.3 million in the three and nine months ended January 31, 2022, respectively.
We disaggregated revenue by Research Publishing & Research Platforms to reflect the different type of products and services provided.
Research Publishing Products
Research Publishing products provide scientific, technical, medical, and scholarly journals, as well as related content and services, to academic, corporate, and government libraries, learned societies, and individual researchers and other professionals. Research Publishing revenue was $248.9 million and $775.1 million in the three and nine months ended January 31, 2022, respectively and the majority is recognized over time.
15
INDEX

Research Publishing products generate approximately 77% and 79% in the three and nine months ended January 31, 2022, respectively of its revenue from contracts with its customers from Journal Subscriptions (pay to read), Open Access (pay to publish) and Transitional Agreements (read and publish), sometimes referred to as Comprehensive Agreements, and the remainder from Licensing, Reprints, Backfiles, and Other.
Research Platforms Services
Research Platforms is principally comprised of Atypon, a publishing software and service provider that enables scholarly and professional societies and publishers to deliver, host, enhance, market, and manage their content on the web through the Literatum platform. Research Platforms revenue was $14.5 million and $38.1 million in the three and nine months ended January 31, 2022, respectively and the majority is recognized over time.
Academic & Professional Learning
Academic & Professional Learning provides Education Publishing and Professional Learning products and services including scientific, professional, and education print and digital books, digital courseware, and test preparation services, to libraries, corporations, students, professionals, and researchers, as well as learning, development, and assessment services for businesses and professionals. Communities served include business, finance, accounting, workplace learning, management, leadership, technology, behavioral health, engineering/ architecture, science and medicine, and education. Products are developed for worldwide distribution through multiple channels, including chain and online booksellers, libraries, colleges and universities, corporations, direct to consumer, web sites, distributor networks and other online applications. Publishing centers include Australia, Germany, India, the UK, and the US. Total Academic & Professional Learning revenue was $170.6 million and $486.4 million in the three and nine months ended January 31, 2022, respectively.
We disaggregated revenue by type of products provided. Academic & Professional Learning products are Education Publishing and Professional Learning. Academic & Professional Learning revenues are mainly recognized at a point in time.
Education Publishing Products
Education Publishing products revenue was $95.5 million and $260.5 million in the three and nine months ended January 31, 2022, respectively. Education Publishing products generate approximately 60% and 65% in the three and nine months ended January 31, 2022, respectively of its revenue from contracts with its customers from Education (print and digital) Publishing, which is recognized at a point in time, and 25% and 20% in the three and nine months ended January 31, 2022, respectively from Digital Courseware which is recognized over time. The remainder of its revenues were from Test Preparation and Certification and Licensing and Other, which has a mix of revenue recognized at a point in time and over time.
Professional Learning Products
Professional Learning products revenue was $75.1 million and $226.0 million in the three and nine months ended January 31, 2022, respectively. Professional Learning (print and digital) products generate approximately 64% and 62% in the three and nine months ended January 31, 2022 of revenue from contracts with its customers from Professional Publishing, and Licensing and Other, and both are mainly recognized at a point in time. Approximately 36% and 38% of Professional Learning products revenue in the three and nine months ended January 31, 2022 is from contracts with its customers from Corporate Training and Corporate Learning, which is recognized mainly over time.
Education Services
Education Services revenue was $81.9 million and $237.6 million in the three and nine months ended January 31, 2022, respectively and the majority is recognized over time. We disaggregated revenue by type of services provided, which are University Services (previously referred to as Education Services OPM) and Talent Development Services (previously referred to as mthree).
University Services
University Services revenue was $55.1 million and $167.6 million in the three and nine months ended January 31, 2022, respectively and is mainly recognized over time. University Services primarily engages in the comprehensive management of online degree programs for universities and has grown to include a broad array of tech enabled service offerings that address our partner specific pain points. Increasingly, this includes delivering career credentialing education that advances specific careers with in-demand skills.
16
INDEX

Talent Development Services
Talent Development Services revenue was $26.8 million and $70.0 million in the three and nine months ended January 31, 2022, respectively, and is recognized at the point in time the services are provided to its customers. Talent Development Services is a talent placement provider that finds, trains and places job-ready technology talent in roles with leading corporations worldwide.
Accounts Receivable, net and Contract Liability Balances
When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue when, or as, control of the products or services are transferred to the customer and all revenue recognition criteria have been met.
The following table provides information about accounts receivable, net and contract liabilities from contracts with customers.

|  | January 31, 2022 |  |  | April 30, 2021 |  |  | Increase/ (Decrease) |
Balances from contracts with customers: |  |  |  |  |  |  |  |  |
Accounts receivable, net |  | $ | 267,988 |  |  | $ | 311,571 |  |  | $ | (43,583 | )
Contract liabilities (1) |  |  | 355,846 |  |  |  | 545,425 |  |  |  | (189,579 | )
Contract liabilities (included in Other long-term liabilities) |  | $ | 21,921 |  |  | $ | 19,560 |  |  | $ | 2,361 |

(1) | The sales return reserve recorded in Contract liabilities is $39.4 million and $38.0 million, as of January 31, 2022 and April 30, 2021, respectively.

For the nine months ended January 31, 2022, we estimate that we recognized revenue of approximately 98% that was included in the current contract liability balance at April 30, 2021.
The decrease in contract liabilities excluding the sales return reserve, was primarily driven by revenue earned on journal subscription agreements, comprehensive agreements, open access and test preparation and certification offerings, partially offset by renewals of journal subscription agreements and comprehensive agreements, open access, and test preparation and certification offerings.
Remaining Performance Obligations included in Contract Liability
As of January 31, 2022, the aggregate amount of the transaction price allocated to the remaining performance obligations is approximately $377.8 million, which included the sales return reserve of $39.4 million. Excluding the sales return reserve, we expect that approximately $316.5 million will be recognized in the next twelve months with the remaining $21.9 million to be recognized thereafter.
Assets Recognized for the Costs to Fulfill a Contract
Costs to fulfill a contract are directly related to a contract that will be used to satisfy a performance obligation in the future and are expected to be recovered. These costs are amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. These types of costs are incurred in the following product types, (1) Research Platforms services, which includes customer specific implementation costs per the terms of the contract and (2) University Services, which includes customer specific costs to develop courses per the terms of the contract.
Our assets associated with incremental costs to fulfill a contract were $11.3 million and $12.1 million at January 31, 2022 and April 30, 2021, respectively, and are included within Other non-current assets on our Unaudited Condensed Consolidated Statements of Financial Position. We recorded amortization expense of $1.2 million and $4.0 million during the three and nine months ended January 31, 2022, respectively, related to these assets within Cost of sales on our Unaudited Condensed Consolidated Statements of Net Income. We recorded amortization expense of $1.3 million and $3.9 million during the three and nine months ended January 31, 2021, respectively, related to these assets within Cost of sales on our Unaudited Condensed Consolidated Statements of Net Income.
17
INDEX

Sales and value-added taxes are excluded from revenues. Shipping and handling costs, which are primarily incurred within the Academic & Professional Learning segment, occur before the transfer of control of the related goods. Therefore, in accordance with the revenue standard, it is not considered a promised service to the customer and would be considered a cost to fulfill our promise to transfer the goods. Costs incurred for third party shipping and handling are primarily reflected in Operating and administrative expenses on our Unaudited Condensed Consolidated Statements of Net Income. We incurred $7.1 million and $21.1 million in shipping and handling costs in the three and nine months ended January 31, 2022, respectively. We incurred $7.1 million and $20.3 million in shipping and handling costs in the three and nine months ended January 31, 2021, respectively.
Note 5 — Operating Leases
We have contractual obligations as a lessee with respect to offices, warehouses and distribution centers, automobiles, and office equipment.
We determine if an arrangement is a lease at inception of the contract in accordance with guidance detailed in the lease standard and we perform the lease classification test as of the lease commencement date. Right-of-use (ROU) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term.
The present value of the lease payments is calculated using an incremental borrowing rate, which was determined based on the rate of interest that we would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. We use an unsecured borrowing rate and risk-adjust that rate to approximate a collateralized rate.
Under the leasing standard, leases that are more than one year in duration are capitalized and recorded on our Unaudited Condensed Consolidated Statements of Financial Position. Some of our leases offer an option to extend the term of such leases. We utilize the reasonably certain threshold criteria in determining which options we will exercise. Furthermore, some of our lease payments are based on index rates with minimum annual increases. These represent fixed payments and are captured in the future minimum lease payments calculation.
For operating leases, the ROU assets and liabilities are presented on our Unaudited Condensed Consolidated Statement of Financial Position as follows:

|  | January 31, 2022 |  |  | April 30, 2021 |
Operating lease ROU assets |  | $ | 118,155 |  |  | $ | 121,430 |
Short-term portion of operating lease liabilities |  |  | 21,598 |  |  |  | 22,440 |
Operating lease liabilities, non-current |  | $ | 139,587 |  |  | $ | 145,832 |

During the nine months ended January 31, 2022, we added $10.2 million to the ROU assets and $10.1 million to the operating lease liabilities due to new leases, including due to acquisitions, as well as modifications and remeasurements to our existing operating leases.
Our total net lease costs are as follows:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Operating lease cost |  | $ | 6,015 |  |  | $ | 5,652 |  |  | $ | 18,257 |  |  | $ | 18,898 |
Variable lease cost |  |  | 386 |  |  |  | 449 |  |  |  | 1,127 |  |  |  | 1,700 |
Short-term lease cost |  |  | 51 |  |  |  | 34 |  |  |  | 107 |  |  |  | 214 |
Sublease income |  |  | (315 | ) |  |  | (181 | ) |  |  | (706 | ) |  |  | (526 | )
Total net lease cost (1) |  | $ | 6,137 |  |  | $ | 5,954 |  |  | $ | 18,785 |  |  | $ | 20,286 |

(1) | Total net lease cost does not include those costs and sublease income included in Restructuring and related charges (credits) on our Unaudited Condensed Consolidated Statements of Net Income. This includes those operating leases we had identified in the year ended April 30, 2021 as part of our Business Optimization program that would be subleased. See Note 9, “Restructuring and Related Charges (Credits)” for more information on this program.

18
INDEX

Other supplemental information includes the following:

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Weighted-average remaining contractual lease term (years) |  |  | 9 |  |  |  | 9 |
Weighted-average discount rate |  |  | 5.80 | % |  |  | 5.89 | %
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |
Operating cash flows from operating leases |  | $ | 22,486 |  |  | $ | 24,563 |

The table below reconciles the undiscounted cash flows for the first five years and total of the remaining years to the operating lease liabilities recorded in our Unaudited Condensed Consolidated Statement of Financial Position as of January 31, 2022:

Fiscal Year |  | Operating Lease Liabilities |
2022 (remaining 3 months) |  | $ | 7,674 |
2023 |  |  | 28,264 |
2024 |  |  | 26,882 |
2025 |  |  | 25,454 |
2026 |  |  | 22,807 |
Thereafter |  |  | 95,660 |
Total future undiscounted minimum lease payments |  |  | 206,741 |
Less: Imputed interest |  |  | 45,556 |
Present value of minimum lease payments |  |  | 161,185 |
Less: Current portion |  |  | 21,598 |
Noncurrent portion |  | $ | 139,587 |

Note 6 — Stock-Based Compensation
We have stock-based compensation plans under which employees may be granted performance-based stock awards, other restricted stock awards and options. We recognize the grant date fair value of stock-based compensation in net income on a straight-line basis, net of estimated forfeitures over the requisite service period. The measurement of performance for performance-based stock awards is based on actual financial results for targets established up to three years in advance, or less. For the three and nine months ended January 31, 2022, we recognized stock-based compensation expense, on a pretax basis, of $6.3 million and $19.4 million, respectively. For the three and nine months ended January 31, 2021, we recognized stock-based compensation expense, on a pretax basis, of $5.6 million and $14.7 million, respectively.
Performance-Based and Other Restricted Stock Activity
Under the terms of our long-term incentive plans, performance-based restricted unit awards are payable in restricted shares of our Class A Common Stock upon the achievement of certain three-year or less financial performance-based targets. During each three-year period or less, we adjust compensation expense based upon our best estimate of expected performance.
We may also grant individual restricted unit awards payable in restricted shares of our Class A Common Stock to key employees in connection with their employment.
19
INDEX

The following table summarizes awards we granted to employees (shares in thousands):

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Restricted Stock: |  |  |  |  |  |
Awards granted (shares) |  |  | 653 |  |  |  | 691 |
Weighted average fair value of grant |  | $ | 57.00 |  |  | $ | 41.26 |

Stock Option Activity
During the nine months ended January 31, 2022, we granted 290,000 stock option awards. Options are exercisable over a maximum period of ten years from the date of grant. For the nine months ended January 31, 2022, options generally vest 10%, 20%, 30%, and 40% on April 30, or on each anniversary date after the award is granted.
The following table provides the estimated weighted average fair value for options granted during the nine months ended January 31, 2022 using the Black-Scholes option-pricing model, and the significant weighted average assumptions used in their determination.

|  | Nine Months Ended January 31, 2022 |
Weighted average fair value of options on grant date |  | $ | 11.72 |
Weighted average assumptions: |  |  |  |
Expected life of options (years) |  |  | 6.3 |
Risk-free interest rate |  |  | 1.2 | %
Expected volatility |  |  | 30.7 | %
Expected dividend yield |  |  | 2.4 | %
Fair value of common stock on grant date |  | $ | 56.66 |
Exercise price of stock option grant |  | $ | 62.18 |

Prior to the above stock option grants in the nine months ended January 31, 2022, we did no t grant any stock option awards since the year ended April 30, 2016. As of April 30, 2019, all outstanding stock options vested allowing the participant the right to exercise their awards, and there was no unrecognized share-based compensation expense remaining related to those stock options.
Note 7 — Accumulated Other Comprehensive Loss
Changes in Accumulated Other Comprehensive Loss by component, net of tax, for the three and nine months ended January 31, 2022 and 2021 were as follows:

|  | Foreign Currency Translation |  |  | Unamortized Retirement Costs |  |  | Interest Rate Swaps |  |  | Total |
Balance at October 31, 2021 |  | $ | (273,361 | ) |  | $ | (222,492 | ) |  | $ | (2,356 | ) |  | $ | (498,209 | )
Other comprehensive (loss) income before reclassifications |  |  | (15,918 | ) |  |  | 3,275 |  |  |  | 1,174 |  |  |  | (11,469 | )
Amounts reclassified from accumulated other comprehensive loss |  |  | — |  |  |  | 1,413 |  |  |  | 826 |  |  |  | 2,239 |
Total other comprehensive (loss) income |  |  | (15,918 | ) |  |  | 4,688 |  |  |  | 2,000 |  |  |  | (9,230 | )
Balance at January 31, 2022 |  | $ | (289,279 | ) |  | $ | (217,804 | ) |  | $ | (356 | ) |  | $ | (507,439 | )
Balance at April 30, 2021 |  | $ | (257,941 | ) |  | $ | (228,146 | ) |  | $ | (4,703 | ) |  | $ | (490,790 | )
Other comprehensive (loss) income before reclassifications |  |  | (31,338 | ) |  |  | 6,056 |  |  |  | 1,859 |  |  |  | (23,423 | )
Amounts reclassified from accumulated other comprehensive loss |  |  | — |  |  |  | 4,286 |  |  |  | 2,488 |  |  |  | 6,774 |
Total other comprehensive (loss) income |  |  | (31,338 | ) |  |  | 10,342 |  |  |  | 4,347 |  |  |  | (16,649 | )
Balance at January 31, 2022 |  | $ | (289,279 | ) |  | $ | (217,804 | ) |  | $ | (356 | ) |  | $ | (507,439 | )

20
INDEX

|  | Foreign Currency Translation |  |  | Unamortized Retirement Costs |  |  | Interest Rate Swaps |  |  | Total |
Balance at October 31, 2020 |  | $ | (305,476 | ) |  | $ | (230,182 | ) |  | $ | (5,984 | ) |  | $ | (541,642 | )
Other comprehensive income (loss) before reclassifications |  |  | 48,305 |  |  |  | (8,237 | ) |  |  | (381 | ) |  |  | 39,687 |
Amounts reclassified from accumulated other comprehensive loss |  |  | — |  |  |  | 1,463 |  |  |  | 963 |  |  |  | 2,426 |
Total other comprehensive income (loss) |  |  | 48,305 |  |  |  | (6,774 | ) |  |  | 582 |  |  |  | 42,113 |
Balance at January 31, 2021 |  | $ | (257,171 | ) |  | $ | (236,956 | ) |  | $ | (5,402 | ) |  | $ | (499,529 | )
Balance at April 30, 2020 |  | $ | (340,703 | ) |  | $ | (227,920 | ) |  | $ | (6,874 | ) |  | $ | (575,497 | )
Other comprehensive income (loss) before reclassifications |  |  | 83,532 |  |  |  | (13,527 | ) |  |  | (1,302 | ) |  |  | 68,703 |
Amounts reclassified from accumulated other comprehensive loss |  |  | — |  |  |  | 4,491 |  |  |  | 2,774 |  |  |  | 7,265 |
Total other comprehensive income (loss) |  |  | 83,532 |  |  |  | (9,036 | ) |  |  | 1,472 |  |  |  | 75,968 |
Balance at January 31, 2021 |  | $ | (257,171 | ) |  | $ | (236,956 | ) |  | $ | (5,402 | ) |  | $ | (499,529 | )

During the three and nine months ended January 31, 2022, pretax actuarial losses included in Unamortized Retirement Costs of approximately $1.8 million and $5.5 million, respectively, and in the three and nine months ended January 31, 2021, approximately $1.9 million and $5.8 million, respectively, were amortized from Accumulated other comprehensive loss and recognized as pension and post-retirement benefit expense primarily in Operating and administrative expenses and Other income, net on our Unaudited Condensed Consolidated Statements of Net Income.
Our policy for releasing the income tax effects from accumulated other comprehensive (loss) income is to release when the corresponding pretax accumulated other comprehensive (loss) income items are reclassified to earnings.
Note 8 — Reconciliation of Weighted Average Shares Outstanding
A reconciliation of the shares used in the computation of earnings per share follows (shares in thousands):

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Weighted average shares outstanding |  |  | 55,701 |  |  |  | 55,984 |  |  |  | 55,789 |  |  |  | 55,968 |
Less: Unvested restricted shares |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | )
Shares used for basic earnings per share |  |  | 55,701 |  |  |  | 55,984 |  |  |  | 55,789 |  |  |  | 55,967 |
Dilutive effect of unvested restricted stock units and other stock awards |  |  | 688 |  |  |  | 348 |  |  |  | 692 |  |  |  | 263 |
Shares used for diluted earnings per share |  |  | 56,389 |  |  |  | 56,332 |  |  |  | 56,481 |  |  |  | 56,230 |
Antidilutive options to purchase Class A common shares, restricted shares, warrants to purchase Class A common shares, and contingently issuable restricted stock which are excluded from the table above |  |  | 977 |  |  |  | 1,281 |  |  |  | 863 |  |  |  | 1,323 |

The shares associated with performance-based stock awards are considered contingently issuable shares and will be included in the diluted weighted average number of common shares outstanding when they have met the performance conditions, and when their effect is dilutive.
We included contingently issuable shares using the treasury stock method for our PSU awards in the diluted weighted average number of common shares outstanding based on the number of contingently issuable shares that would be issued assuming the end of our reporting period was the end of the relevant PSU award contingency period. The calculation of diluted weighted average shares outstanding related to performance-based stock awards was nominal in the three and nine months ended January 31, 2022.
21
INDEX

Note 9 — Restructuring and Related Charges (Credits)
Beginning in fiscal year 2020, we initiated a multiyear Business Optimization Program (the Business Optimization Program) to drive efficiency improvement and operating savings.
The following tables summarize the pretax restructuring charges (credits) related to this program:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |  |  | Total Charges |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |  |  | Incurred to Date |
Charges (Credits) by Segment: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing & Platforms |  | $ | — |  |  | $ | 83 |  |  | $ | 238 |  |  | $ | (217 | ) |  | $ | 3,883 |
Academic & Professional Learning |  |  | 215 |  |  |  | 314 |  |  |  | (79 | ) |  |  | 1,628 |  |  |  | 13,625 |
Education Services |  |  | 5 |  |  |  | 71 |  |  |  | (23 | ) |  |  | 294 |  |  |  | 4,282 |
Corporate Expenses |  |  | 228 |  |  |  | 20,193 |  |  |  | (1,297 | ) |  |  | 23,247 |  |  |  | 43,311 |
Total Restructuring and Related Charges (Credits) |  | $ | 448 |  |  | $ | 20,661 |  |  | $ | (1,161 | ) |  | $ | 24,952 |  |  | $ | 65,101 |
Charges (Credits) by Activity: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Severance and termination benefits |  | $ | (291 | ) |  | $ | 825 |  |  | $ | (2,861 | ) |  | $ | 3,618 |  |  | $ | 35,534 |
Impairment of operating lease ROU assets and property and equipment |  |  | — |  |  |  | 14,924 |  |  |  | — |  |  |  | 14,924 |  |  |  | 15,079 |
Acceleration of expense related to operating lease ROU assets and property and equipment |  |  | — |  |  |  | 3,378 |  |  |  | — |  |  |  | 3,378 |  |  |  | 3,378 |
Facility related charges, net |  |  | 739 |  |  |  | 1,614 |  |  |  | 1,700 |  |  |  | 3,112 |  |  |  | 9,370 |
Other activities |  |  | — |  |  |  | (80 | ) |  |  | — |  |  |  | (80 | ) |  |  | 1,740 |
Total Restructuring and Related Charges (Credits) |  | $ | 448 |  |  | $ | 20,661 |  |  | $ | (1,161 | ) |  | $ | 24,952 |  |  | $ | 65,101 |

The credits in severance and termination benefits activities for the three and nine months ended January 31, 2022, primarily reflects changes in the number of headcount reductions and estimates for previously accrued costs.
The charges in Impairment of operating lease ROU assets and property and equipment and Acceleration of expense related to operating lease ROU assets and property and equipment for the three and nine months ended January 31, 2021 reflects the expansion of the scope of the Business Optimization Program to include the exit of certain leased office space which began in the third quarter of fiscal 2021, and the reduction of our occupancy at other facilities.
Facilities related charges, net include sublease income related to those operating leases we had identified in the year ended April 30, 2021 as part of our Business Optimization program that would be subleased.
The following table summarizes the activity for the Business Optimization Program liability for the nine months ended January 31, 2022:

|  | April 30, 2021 |  |  | (Credits) |  |  | Payments |  |  | Foreign Translation & Other Adjustments |  |  | January 31, 2022 |
Severance and termination benefits |  | $ | 11,465 |  |  | $ | (2,861 | ) |  | $ | (5,225 | ) |  | $ | (194 | ) |  | $ | 3,185 |
Total |  | $ | 11,465 |  |  | $ | (2,861 | ) |  | $ | (5,225 | ) |  | $ | (194 | ) |  | $ | 3,185 |

The restructuring liability for accrued severance and termination benefits is reflected in Accrued employment costs on our Unaudited Condensed Consolidated Statement of Financial Position as of January 31, 2022.
22
INDEX

Note 10 — Segment Information
We report our segment information in accordance with the provisions of FASB Accounting Standards Codification (ASC) Topic 280, “Segment Reporting”. These segments reflect the way our chief operating decision maker evaluates our business performance and manages the operations. The performance metric used by our chief operating decision maker to evaluate performance of our reportable segments is Adjusted Contribution to Profit. Our segment reporting structure consists of three reportable segments, which are listed below, as well as a Corporate category, which includes certain costs that are not allocated to the reportable segments:

| ● | Research Publishing & Platforms

| ● | Academic & Professional Learning

| ● | Education Services

Segment information is as follows:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing & Platforms |  | $ | 263,341 |  |  | $ | 239,850 |  |  | $ | 813,251 |  |  | $ | 731,994 |
Academic & Professional Learning (1) |  |  | 170,633 |  |  |  | 173,626 |  |  |  | 486,426 |  |  |  | 469,971 |
Education Services (1) |  |  | 81,910 |  |  |  | 69,436 |  |  |  | 237,598 |  |  |  | 203,284 |
Total revenue |  | $ | 515,884 |  |  | $ | 482,912 |  |  | $ | 1,537,275 |  |  | $ | 1,405,249 |
Adjusted Contribution to Profit: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing & Platforms |  | $ | 62,165 |  |  | $ | 60,865 |  |  | $ | 218,242 |  |  | $ | 204,336 |
Academic & Professional Learning (1) |  |  | 34,989 |  |  |  | 33,151 |  |  |  | 83,918 |  |  |  | 64,454 |
Education Services (1) |  |  | 2,659 |  |  |  | 5,281 |  |  |  | 1,525 |  |  |  | 13,256 |
Total adjusted contribution to profit |  |  | 99,813 |  |  |  | 99,297 |  |  |  | 303,685 |  |  |  | 282,046 |
Adjusted corporate contribution to profit |  |  | (53,376 | ) |  |  | (44,295 | ) |  |  | (144,001 | ) |  |  | (122,962 | )
Total adjusted contribution to profit |  | $ | 46,437 |  |  | $ | 55,002 |  |  | $ | 159,684 |  |  | $ | 159,084 |
Depreciation and Amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing & Platforms |  | $ | 23,914 |  |  | $ | 20,997 |  |  | $ | 71,140 |  |  | $ | 60,463 |
Academic & Professional Learning (1) |  |  | 17,038 |  |  |  | 17,233 |  |  |  | 53,550 |  |  |  | 53,757 |
Education Services (1) |  |  | 8,260 |  |  |  | 7,493 |  |  |  | 25,376 |  |  |  | 21,982 |
Total depreciation and amortization |  |  | 49,212 |  |  |  | 45,723 |  |  |  | 150,066 |  |  |  | 136,202 |
Corporate depreciation and amortization |  |  | 4,151 |  |  |  | 3,593 |  |  |  | 12,418 |  |  |  | 11,051 |
Total depreciation and amortization |  | $ | 53,363 |  |  | $ | 49,316 |  |  | $ | 162,484 |  |  | $ | 147,253 |

(1) | In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning to Education Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services. The Revenue, Adjusted Contribution to Profit and Depreciation and Amortization for WileyNXT was $0.5 million, $(0.2) million, and none, respectively, for the three months ended January 31, 2021. The Revenue, Adjusted Contribution to Profit and Depreciation and Amortization for WileyNXT was $1.6 million, $(0.4) million, and none, respectively, for the nine months ended January 31, 2021. There were no changes to our total consolidated financial results.

23
INDEX

The following table shows a reconciliation of our consolidated US GAAP Operating Income to Non-GAAP Adjusted Contribution to Profit:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
US GAAP Operating Income |  | $ | 45,989 |  |  | $ | 34,327 |  |  | $ | 160,845 |  |  | $ | 134,271 |
Adjustments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring and related charges (credits) (1) |  |  | 448 |  |  |  | 20,675 |  |  |  | (1,161 | ) |  |  | 24,813 |
Non-GAAP Adjusted Contribution to Profit |  | $ | 46,437 |  |  | $ | 55,002 |  |  | $ | 159,684 |  |  | $ | 159,084 |

(1) | See Note 9, “Restructuring and Related Charges (Credits)” for these charges by segment.

See Note 4, “Revenue Recognition, Contracts with Customers,” for revenue from contracts with customers disaggregated by segment and product type for the three and nine months ended January 31, 2022 and 2021.
Note 11 — Inventories
Inventories, net consisted of the following:

|  | January 31, 2022 |  |  | April 30, 2021 |
Finished goods |  | $ | 29,613 |  |  | $ | 31,704 |
Work-in-process |  |  | 2,053 |  |  |  | 2,060 |
Paper and other materials |  |  | 260 |  |  |  | 331 |
Total inventories before estimated sales returns and LIFO reserve |  | $ | 31,926 |  |  | $ | 34,095 |
Inventory value of estimated sales returns |  |  | 10,243 |  |  |  | 10,886 |
LIFO reserve |  |  | (2,443 | ) |  |  | (2,443 | )
Inventories, net |  | $ | 39,726 |  |  | $ | 42,538 |

Note 12 — Goodwill and Intangible Assets
Goodwill
The following table summarizes the activity in goodwill by segment as of January 31, 2022:

|  | April 30, 2021 (1) |  |  | Acquisitions (2) |  |  | Foreign Translation Adjustment |  |  | January 31, 2022 |
Research Publishing & Platforms |  | $ | 619,203 |  |  | $ | 21,252 |  |  | $ | (12,443 | ) |  | $ | 628,012 |
Academic & Professional Learning |  |  | 512,512 |  |  |  | — |  |  |  | (8,243 | ) |  |  | 504,269 |
Education Services |  |  | 172,625 |  |  |  | 21,619 |  |  |  | (561 | ) |  |  | 193,683 |
Total |  | $ | 1,304,340 |  |  | $ | 42,871 |  |  | $ | (21,247 | ) |  | $ | 1,325,964 |

(1) | The Education Services goodwill balance as of April 30, 2021 includes a cumulative pretax noncash goodwill impairment of $110.0 million.

(2) | Refer to Note 3, “Acquisitions,” for more information related to the acquisitions that occurred in the nine months ended January 31, 2022.

24
INDEX

Intangible Assets
Intangible assets, net were as follows:

|  | January 31, 2022 |  |  | April 30, 2021 (1) |
Intangible assets with definite lives, net (2): |  |  |  |  |  |
Content and publishing rights |  | $ | 522,090 |  |  | $ | 564,229 |
Customer relationships |  |  | 249,136 |  |  |  | 266,477 |
Developed technology |  |  | 58,940 |  |  |  | 34,961 |
Brands and trademarks |  |  | 17,097 |  |  |  | 19,536 |
Covenants not to compete |  |  | 416 |  |  |  | 58 |
Total intangible assets with definite lives, net |  |  | 847,679 |  |  |  | 885,261 |
Intangible assets with indefinite lives: |  |  |  |  |  |  |  |
Brands and trademarks |  |  | 37,000 |  |  |  | 37,000 |
Publishing rights |  |  | 86,214 |  |  |  | 93,041 |
Total intangible assets with indefinite lives |  |  | 123,214 |  |  |  | 130,041 |
Total intangible assets, net |  | $ | 970,893 |  |  | $ | 1,015,302 |

(1) | The developed technology balance as of April 30, 2021 is presented net of accumulated impairments and write-offs of $2.8 million. The indefinite-lived brands and trademarks as of April 30, 2021 is net of accumulated impairments of $93.1 million.

(2) | Refer to Note 3, “Acquisitions,” for more information related to the acquisitions that occurred in the nine months ended January 31, 2022.

Note 13 — Income Taxes
The effective tax rate for the three and nine months ended January 31, 2022 was 18.2% and 33.4%, respectively, compared with 19.1% and 14.9% for the three and nine months ended January 31, 2021, respectively.
The rate for the three months ended January 31, 2022 was lower than the US statutory rate, as well as the rate for the three months ended January 31, 2021 primarily due to the mix of income at lower rates as well as certain discrete items realized during the three months ended January 31, 2022. The rate for the nine months ended January 31, 2022, was greater than the US statutory rate as well as the rate for the nine months ended January 31, 2021 due to an increase in the UK statutory rate, resulting in a noncash deferred tax expense from the re-measurement of our applicable UK net deferred tax liabilities.
The increase in the UK statutory rate during the nine months ended January 31, 2022 was larger than the increase during the nine months ended January 31, 2021. In addition, during the nine months ended January 31, 2021, as a result of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and certain regulations issued in late July 2020, we carried back certain US net operating losses (NOLs) to a year with a higher statutory tax rate, decreasing the rate for the nine months ended January 31, 2021.
During the nine months ended January 31, 2022, the UK enacted legislation that increased its statutory rate from 19% to 25% effective April 1, 2023, resulting in a $20.7 million non-cash deferred tax expense. During the nine months ended January 31, 2021, the UK officially enacted legislation that increased its statutory rate from 17% to 19%, resulting in a $6.7 million non-cash deferred tax expense.
25
INDEX

Note 14 — Retirement Plans
The components of net pension income for our defined benefit plans were as follows:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Service cost |  | $ | 291 |  |  | $ | 356 |  |  | $ | 898 |  |  | $ | 1,036 |
Interest cost |  |  | 5,122 |  |  |  | 4,564 |  |  |  | 15,523 |  |  |  | 13,695 |
Expected return on plan assets |  |  | (9,986 | ) |  |  | (9,853 | ) |  |  | (30,387 | ) |  |  | (28,880 | )
Amortization of prior service cost |  |  | (23 | ) |  |  | (23 | ) |  |  | (67 | ) |  |  | (72 | )
Amortization of net actuarial loss |  |  | 1,858 |  |  |  | 1,944 |  |  |  | 5,632 |  |  |  | 5,964 |
Net pension income |  | $ | (2,738 | ) |  | $ | (3,012 | ) |  | $ | (8,401 | ) |  | $ | (8,257 | )

The service cost component of net pension income is reflected in Operating and administrative expenses on our Unaudited Condensed Consolidated Statements of Net Income. The other components of net pension income are reported separately from the service cost component and below Operating income. Such amounts are reflected in Other income, net on our Unaudited Condensed Consolidated Statements of Net Income.
Employer defined benefit pension plan contributions were $3.4 million and $11.9 million for the three and nine months ended January 31, 2022, respectively, and $3.6 million and $12.5 million for the three and nine months ended January 31, 2021, respectively.
Defined Contribution Savings Plans
The expense for employer defined contribution savings plans was $7.2 million and $22.8 million for the three and nine months ended January 31, 2022, respectively, and $5.6 million and $17.4 million for the three and nine months ended January 31, 2021, respectively.
Note 15 — Debt and Available Credit Facilities
Our total debt outstanding consisted of the amounts set forth in the following table:

|  | January 31, 2022 |  |  | April 30, 2021 |
Short-term portion of long-term debt (1) |  | $ | 15,625 |  |  | $ | 12,500 |
Term loan A - Amended and Restated RCA (2) |  |  | 210,552 |  |  |  | 222,928 |
Revolving credit facility - Amended and Restated RCA |  |  | 691,493 |  |  |  | 586,160 |
Total long-term debt, less current portion |  |  | 902,045 |  |  |  | 809,088 |
Total debt |  | $ | 917,670 |  |  | $ | 821,588 |

(1) | Relates to our term loan A under the Amended and Restated RCA.

(2) | Amounts are shown net of unamortized issuance costs of $0.4 million as of January 31, 2022 and $0.5 million as of April 30, 2021.

Amended and Restated RCA
On May 30, 2019, we entered into a credit agreement that amended and restated our existing revolving credit agreement, which was then amended on December 22, 2021 as described below (collectively, the Amended and Restated RCA). The Amended and Restated RCA provides for senior unsecured credit facilities comprised of a (i) five-year revolving credit facility in an aggregate principal amount up to $1.25 billion, and (ii) a five-year term loan A facility consisting of $250 million.
26
INDEX

Under the terms of the Amended and Restated RCA, which can be drawn in multiple currencies, we have the option of borrowing at the following floating interest rates: (i) at a rate based on the London Interbank Offered Rate (LIBOR) plus an applicable margin ranging from 0.98% to 1.50%, depending on our consolidated net leverage ratio, as defined, or (ii) at the lender’s base rate plus an applicable margin ranging from zero to 0.50%, depending on our consolidated net leverage ratio. The lender’s base rate is defined as the highest of (i) the US federal funds effective rate plus a 0.50% margin, (ii) the Eurocurrency rate, as defined, plus a 1.00% margin, or (iii) the Bank of America prime lending rate. In addition, we pay a facility fee for the revolving credit facility ranging from 0.15% to 0.25% depending on our consolidated net leverage ratio. We also have the option to request an increase in the revolving credit facility by an amount not to exceed $500 million, in minimum increments of $50 million, subject to the approval of the lenders.
On December 22, 2021, we entered into the first amendment (the “First Amendment”) to the Amended and Restated RCA. The First Amendment, among other things, (i) changes the rate under the Amended and Restated RCA for borrowings denominated in Sterling from a LIBOR-based rate to a daily simple Sterling Overnight Index Average (SONIA) subject to certain adjustments specified in the Amended and Restated RCA, (ii) changes the rate under the Amended and Restated RCA for borrowings denominated in Euro from a LIBOR-based rate to a EURIBOR-based rate or a Euro Short Term Rate subject to certain adjustments specified in the Amended and Restated RCA, and (iii) updates certain other provisions regarding successor interest rates to LIBOR.
The Amended and Restated RCA contains certain customary affirmative and negative covenants, including a financial covenant in the form of a consolidated net leverage ratio and consolidated interest coverage ratio, which we were in compliance with as of January 31, 2022.
The amortization expense of the costs incurred related to the Amended and Restated RCA related to the lender and non-lender fees is recognized over the five-year term of the Amended and Restated RCA. Total amortization expense was $0.3 million and $0.8 million for the three and nine months ended January 31, 2022, respectively and is included in Interest expense on our Unaudited Condensed Consolidated Statements of Net Income. Total amortization expense was $0.3 million and $0.8 million for the three and nine months ended January 31, 2021, respectively and is included in Interest expense on our Unaudited Condensed Consolidated Statements of Net Income.
As of January 31, 2022, we had approximately $559.5 million of unused borrowing capacity under our Amended and Restated RCA and other facilities.
Note 16 — Derivative Instruments and Hedging Activities
From time-to-time, we enter into forward exchange and interest rate swap contracts as a hedge against foreign currency asset and liability commitments, changes in interest rates and anticipated transaction exposures, including intercompany sales and purchases. All derivatives are recognized as assets or liabilities and measured at fair value. Derivatives that are not determined to be effective hedges are adjusted to fair value with a corresponding adjustment to earnings. We do not use financial instruments for trading or speculative purposes.
Interest Rate Contracts
As of January 31, 2022, we had total debt outstanding of $917.7 million, net of unamortized issuance costs of $0.4 million of which $918.1 million are variable rate loans outstanding under the Amended and Restated RCA, which approximated fair value.
We had outstanding interest rate swap agreements with combined notional amounts of $400.0 million as of January 31, 2022 and April 30, 2021. These agreements were accounted for as cash flow hedges which fixed a portion of the variable interest due on our Amended and Restated RCA.
We record the fair value of our interest rate swaps on a recurring basis using Level 2 inputs of quoted prices for similar assets or liabilities in active markets. The fair value of the interest rate swaps as of January 31, 2022 was a deferred loss of $1.5 million and a deferred gain of $1.7 million. Based on the maturity dates of the contracts, $1.1 million of the deferred loss as of January 31, 2022 was recorded within Other accrued liabilities and $0.4 million of the deferred loss was recorded within Other long-term liabilities. The deferred gain was recorded within Other non-current assets.
The fair value of the interest rate swaps as of April 30, 2021 was a deferred loss of $5.6 million. Based on the maturity dates of the contracts, the entire deferred loss as of April 30, 2021 was recorded within Other long-term liabilities.
27
INDEX

The pretax losses that were reclassified from Accumulated other comprehensive loss into Interest expense for the three and nine months ended January 31, 2022 were $1.1 million and $3.3 million, respectively. The pretax losses that were reclassified from Accumulated other comprehensive loss into Interest expense for the three and nine months ended January 31, 2021 were $1.0 million and $2.8 million, respectively.
Foreign Currency Contracts
We may enter into forward exchange contracts to manage our exposure on certain foreign currency denominated assets and liabilities. The forward exchange contracts are marked to market through Foreign exchange transaction losses on our Unaudited Condensed Consolidated Statements of Net Income and carried at fair value on our Unaudited Condensed Consolidated Statements of Financial Position. Foreign currency denominated assets and liabilities are remeasured at spot rates in effect on the balance sheet date, with the effects of changes in spot rates reported in Foreign exchange transaction losses on our Unaudited Condensed Consolidated Statements of Net Income.
As of January 31, 2022, and April 30, 2021, we did not maintain any open forward exchange contracts. In addition, we did not maintain any open forward contracts during the nine months ended January 31, 2022.
As of January 31, 2021, there was an open forward exchange contract to sell €32.0 million and buy $38.8 million to manage foreign currency exposures on intercompany loans. This forward contract expired on April 15, 2021. We did not designate this forward exchange contract as a hedge under the applicable sections of ASC Topic 815, “Derivatives and Hedging” as the benefits of doing so were not material due to the short-term nature of the contract. The fair value changes in the forward exchange contract substantially mitigated the changes in the value of the applicable foreign currency denominated liability. As of January 31, 2021, the fair value of the open forward exchange contracts was an immaterial gain and recorded within Prepaid expenses and other current assets. The fair value of the open forward exchange contract was measured on a recurring basis using Level 2 inputs of quoted prices for similar assets or liabilities in active markets. For the three and nine months ended January 31, 2021, the gain recognized on this forward contract was immaterial and included in Foreign exchange transaction losses on our Unaudited Condensed Consolidated Statement of Net Income.
Note 17 — Capital Stock and Changes in Capital Accounts
Share Repurchases
The following table summarizes the share repurchases of Class A and Class B Common Stock (shares in thousands):

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Shares repurchased - Class A |  |  | 134 |  |  |  | 146 |  |  |  | 446 |  |  |  | 146 |
Shares repurchased - Class B |  |  | 1 |  |  |  | 1 |  |  |  | 2 |  |  |  | 1 |
Average Price - Class A and Class B |  | $ | 55.40 |  |  | $ | 48.09 |  |  | $ | 55.48 |  |  | $ | 48.09 |

Dividends
The following table summarizes the cash dividends paid during the nine months ended January 31, 2022:

Date of Declaration by Board of Directors |  | Quarterly Cash Dividend |  | Total Dividend |  | Class of Common Stock |  | Dividend Paid Date |  | Shareholders of Record as of Date
June 22, 2021 |  | $0.3450 per common share |  | $19.3 million |  | Class A and Class B |  | July 21, 2021 |  | July 6, 2021
September 29, 2021 |  | $0.3450 per common share |  | $19.2 million |  | Class A and Class B |  | October 27, 2021 |  | October 12, 2021
December 15, 2021 |  | $0.3450 per common share |  | $19.2 million |  | Class A and Class B |  | January 12, 2022 |  | December 28, 2021

28
INDEX

Changes in Common Stock
The following is a summary of changes during the nine months ended January 31, in shares of our common stock and common stock in treasury (shares in thousands):

Changes in Common Stock A: |  | 2022 |  |  | 2021 |
Number of shares, beginning of year |  |  | 70,208 |  |  |  | 70,166 |
Common stock class conversions |  |  | 10 |  |  |  | 42 |
Number of shares issued, end of period |  |  | 70,218 |  |  |  | 70,208 |
Changes in Common Stock A in treasury: |  |  |  |  |  |  |  |
Number of shares held, beginning of year |  |  | 23,419 |  |  |  | 23,405 |
Purchases of treasury shares |  |  | 446 |  |  |  | 146 |
Restricted shares issued under stock-based compensation plans – non-PSU Awards |  |  | (163 | ) |  |  | (100 | )
Restricted shares issued under stock-based compensation plans – PSU Awards |  |  | (108 | ) |  |  | (88 | )
Shares issued under the Director Plan to Directors |  |  | (2 | ) |  |  | (6 | )
Restricted shares issued from exercise of stock options |  |  | (24 | ) |  |  | (33 | )
Shares issued related to the acquisition of a business |  |  | (129 | ) |  |  | — |
Shares withheld for taxes |  |  | 110 |  |  |  | 70 |
Number of shares held, end of period |  |  | 23,549 |  |  |  | 23,394 |
Number of Common Stock A outstanding, end of period |  |  | 46,669 |  |  |  | 46,814 |

Changes in Common Stock B: |  | 2022 |  |  | 2021 |
Number of shares, beginning of year |  |  | 12,974 |  |  |  | 13,016 |
Common stock class conversions |  |  | (10 | ) |  |  | (42 | )
Number of shares issued, end of period |  |  | 12,964 |  |  |  | 12,974 |
Changes in Common Stock B in treasury: |  |  |  |  |  |  |  |
Number of shares held, beginning of year |  |  | 3,922 |  |  |  | 3,920 |
Purchase of treasury shares |  |  | 2 |  |  |  | 1 |
Number of shares held, end of period |  |  | 3,924 |  |  |  | 3,921 |
Number of Common Stock B outstanding, end of period |  |  | 9,040 |  |  |  | 9,053 |

Note 18 — Commitments and Contingencies
We are involved in routine litigation in the ordinary course of our business. A provision for litigation is accrued when information available to us indicates that it is probable a liability has been incurred and the amount of loss can be reasonably estimated. Significant judgment may be required to determine both the probability and estimates of loss. When the amount of the loss can only be estimated within a range, the most likely outcome within that range is accrued. If no amount within the range is a better estimate than any other amount, the minimum amount within the range is accrued. When uncertainties exist related to the probable outcome of litigation and/or the amount or range of loss, we do not record a liability, but disclose facts related to the nature of the contingency and possible losses if management considers the information to be material. Reserves for legal defense costs are recognized when incurred. The accruals for loss contingencies and legal costs are reviewed regularly and may be adjusted to reflect updated information on the status of litigation and advice of legal counsel. In the opinion of management, the ultimate resolution of all pending litigation as of January 31, 2022, will not have a material effect upon our consolidated financial condition or results of operations.
29
INDEX

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The information in our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read together with our Condensed Consolidated Financial Statements and related notes set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q, our MD&A set forth in Item 7 of Part II of our 2021 Form 10-K and our Consolidated Financial Statements and related notes set forth in Item 8 of Part II of our 2021 Form 10-K. See Part II, Item 1A, “Risk Factors,” below and “Cautionary Notice Regarding Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995,” above, and the information referenced therein, for a description of risks that we face and important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. All amounts and percentages are approximate due to rounding and all dollars are in thousands, except per share amounts or where otherwise noted. When we cross-reference to a “Note,” we are referring to our “Notes to Unaudited Condensed Consolidated Financial Statements,” unless the context indicates otherwise.
OVERVIEW
Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Wiley is a predominantly digital company with over 80% of revenue for the nine months ended January 31, 2022 generated by digital products and services.
We report financial information for the following segments, as well as a Corporate category, which includes certain costs that are not allocated to the reportable segments:

• | Research Publishing & Platforms

• | Academic & Professional Learning

• | Education Services

Through the Research Publishing & Platforms segment, we provide peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Academic & Professional Learning segment provides Education Publishing and Professional Learning content and courseware, training and learning services, to students, professionals, and corporations. The Education Services segment provides online program management (OPM) services for academic institutions and talent development services for professionals and businesses.
Wiley’s business strategies are tightly aligned with accelerating growth trends, including open research, career-connected education, and talent development. Research strategies include driving publishing output to meet the increasing demand for peer-reviewed research and expanding platform and service offerings for corporations and societies. Education strategies include expanding online degree programs and driving online enrollment for university partners, scaling digital content and courseware, and expanding IT talent placement and reskilling programs for corporate partners.
Wiley has operations in Russia consisting primarily of technology development resources. We have exercised contingency plans to minimize any disruption if we were to lose access to our staff. If that should occur, we believe it will not materially impact our overall operations. As of January 31, 2022, the net assets of our Russian operations were not material to our overall financial position. We have customers in Russia, primarily for our Research offerings, which are not material to our overall financial results. We do not have operations in Ukraine or Belarus and the business conducted in those countries are also not material to our overall financial results.
RESULTS OF OPERATIONS – THREE MONTHS ENDED JANUARY 31, 2022
THIRD QUARTER SUMMARY:

• | US GAAP Results: Consolidated Revenue of $516 million (+7%, compared with the prior year), Operating Income of $46 million (+34%, compared with the prior year), and EPS of $0.63 (+62%, compared with the prior year)

• | Adjusted Results (at constant currency compared with the prior year): Consolidated Revenue of $516 million (+7%, compared with the prior year), Adjusted EBITDA of $100 million (-5%, compared with the prior year), and Adjusted EPS of $0.95 (-9%, compared with the prior year)

• | Acquisitions: In the three months ended January 31, 2022, we completed three acquisitions, including acquiring the assets of XYZ Media Inc. (Education Services segment)

30
INDEX

CONSOLIDATED RESULTS OF OPERATIONS
Revenue:
Revenue for the three months ended January 31, 2022 increased $33.0 million, or 7%, as compared with the prior year on a reported basis and on a constant currency basis including contributions from acquisitions. Excluding the contributions from acquisitions, revenue increased 4% on a constant currency basis.
See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.
Cost of Sales:
Cost of sales for the three months ended January 31, 2022 increased $15.3 million, or 10%, as compared with the prior year on a reported and on a constant currency basis as compared with the prior year. This increase was primarily due to higher employee costs and, to a lesser extent, higher student acquisition costs in Education Services, as well as increased royalty costs in Research Publishing & Platforms.
Operating and Administrative Expenses:
Operating and administrative expenses for the three months ended January 31, 2022 increased $24.2 million, or 10%, as compared with the prior year. On a constant currency basis, operating and administrative expenses increased 11% as compared with the prior year primarily reflecting higher technology costs, editorial costs due to additional resources to support investments in growth and, to a lesser extent, advertising and marketing costs.
Restructuring and Related Charges (Credits):
For the three months ended January 31, 2022 and 2021, we recorded pretax restructuring charges of $0.4 million and $20.7 million, respectively, primarily related to our Business Optimization Program. We anticipate $10.0 million in run rate savings from actions starting in fiscal 2022. These charges are reflected in Restructuring and related charges (credits) in our Unaudited Condensed Consolidated Statements of Net Income. See Note 9, “Restructuring and Related Charges (Credits)” for more details on these charges.
In November 2020, in response to the COVID-19 pandemic and the Company’s successful transition to a virtual work environment, we increased use of virtual work arrangements for post-pandemic operations. As a result, we expanded the scope of the Business Optimization Program to include the exit of certain leased office space beginning in the third quarter of fiscal 2021, and the reduction of our occupancy at other facilities. We are reducing our real estate square footage occupancy by approximately 12%.
These actions yielded annualized cost savings of approximately $8.0 million. We anticipate ongoing facility-related costs associated with certain properties to result in additional restructuring charges in future periods.
For the impact of our restructuring program on diluted earnings per share, see the section below, “Diluted Earnings per Share (EPS).”
Amortization of Intangible Assets:
Amortization of intangible assets was $21.1 million for the three months ended January 31, 2022, an increase of $2.0 million, or 11%, as compared with the prior year on a reported and constant currency basis. This increase was primarily due to the intangible assets acquired as part of the Hindawi acquisition completed in fiscal year 2021 and, to a lesser extent, other acquisitions completed in fiscal year 2022. See Note 3, “Acquisitions” for more details on our acquisitions.
Operating Income, Adjusted Contribution to Profit (CTP) and Adjusted EBITDA:
Operating income for the three months ended January 31, 2022 increased $11.7 million, or 34%, as compared with the prior year. On a constant currency basis, operating income increased 31% as compared with the prior year, primarily due to the increase in revenue and, to a lesser extent, lower restructuring charges, partially offset by an increase in operating and administrative expenses and cost of sales.
31
INDEX

Adjusted CTP and Adjusted EBITDA on a constant currency basis and excluding restructuring charges, decreased 17% and 5%, respectively, as compared with the prior year. The decrease in Adjusted CTP and Adjusted EBITDA was primarily due to an increase in operating and administrative expenses, and cost of sales, partially offset by revenue performance described above. In addition, the decrease in Adjusted CTP reflected higher depreciation and amortization.
Adjusted CTP
Below is a reconciliation of our consolidated US GAAP Operating Income to Non-GAAP Adjusted CTP:

|  | Three Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP Operating Income |  | $ | 45,989 |  |  | $ | 34,327 |
Adjustments: |  |  |  |  |  |  |  |
Restructuring and related charges |  |  | 448 |  |  |  | 20,675 |
Non-GAAP Adjusted CTP |  | $ | 46,437 |  |  | $ | 55,002 |

Adjusted EBITDA
Below is a reconciliation of our consolidated US GAAP Net Income to Non-GAAP EBITDA and Adjusted EBITDA:

|  | Three Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Net Income |  | $ | 35,366 |  |  | $ | 22,161 |
Interest expense |  |  | 5,103 |  |  |  | 4,853 |
Provision for income taxes |  |  | 7,853 |  |  |  | 5,231 |
Depreciation and amortization |  |  | 53,363 |  |  |  | 49,316 |
Non-GAAP EBITDA |  |  | 101,685 |  |  |  | 81,561 |
Restructuring and related charges |  |  | 448 |  |  |  | 20,675 |
Foreign exchange transaction losses |  |  | 488 |  |  |  | 5,694 |
Other income, net |  |  | (2,821 | ) |  |  | (3,612 | )
Non-GAAP Adjusted EBITDA |  | $ | 99,800 |  |  | $ | 104,318 |

Interest Expense:
Interest expense for the three months ended January 31, 2022 was $5.1 million compared with the prior year of $4.9 million. This increase was due to a higher weighted average effective interest rate and, to a lesser extent, higher average debt balance outstanding, which included borrowings for the funding of acquisitions.
Foreign Exchange Transaction Losses:
Foreign exchange transaction losses were $0.5 million for the three months ended January 31, 2022 and were primarily due to losses on our foreign currency denominated intercompany and, to a lesser extent, third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.
Foreign exchange transaction losses were $5.7 million for the three months ended January 31, 2021. The losses were primarily due to the unfavorable impact of the changes in exchange rates on US Dollar cash balances held in the UK to fund the acquisition of Hindawi.
32
INDEX

Provision for Income Taxes:
Below is a reconciliation of our US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes:

|  | Three Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP Income Before Taxes |  | $ | 43,219 |  |  | $ | 27,392 |
Pretax Impact of Adjustments: |  |  |  |  |  |  |  |
Restructuring and related charges |  |  | 448 |  |  |  | 20,675 |
Foreign exchange losses on intercompany transactions |  |  | 722 |  |  |  | 267 |
Amortization of acquired intangible assets |  |  | 22,189 |  |  |  | 20,163 |
Non-GAAP Adjusted Income Before Taxes |  | $ | 66,578 |  |  | $ | 68,497 |

Below is a reconciliation of our US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

|  | Three Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP Income Tax Provision |  | $ | 7,853 |  |  | $ | 5,231 |
Income Tax Impact of Adjustments (1): |  |  |  |  |  |  |  |
Restructuring and related charges |  |  | 114 |  |  |  | 4,965 |
Foreign exchange losses on intercompany transactions |  |  | 239 |  |  |  | 87 |
Amortization of acquired intangible assets |  |  | 4,834 |  |  |  | 4,691 |
Non-GAAP Adjusted Income Tax Provision |  | $ | 13,040 |  |  | $ | 14,974 |
US GAAP Effective Tax Rate |  |  | 18.2 | % |  |  | 19.1 | %
Non-GAAP Adjusted Effective Tax Rate |  |  | 19.6 | % |  |  | 21.9 | %

(1) | For the three months ended January 31, 2022 and 2021, substantially all of the tax impact was from deferred taxes.

The US GAAP effective tax rate for the three months ended January 31, 2022 was 18.2% compared with 19.1% for the three months ended January 31, 2021. The Non-GAAP adjusted effective tax rate for the three months ended January 31, 2022 was 19.6%, compared with 21.9% for the three months ended January 31, 2021. The US GAAP effective tax rate and the Non-GAAP adjusted effective tax rate for the three months ended January 31, 2022, were lower than the US statutory rate, as well as the rate for the three months ended January 31, 2021, primarily due to the mix of income at lower rates, as well as certain discrete items realized during the three months ended January 31, 2022.
Diluted Earnings per Share (EPS):
EPS for the three months ended January 31, 2022 was $0.63 per share compared with $0.39 per share for the three months ended January 31, 2021. This increase was due to higher operating income as described above and, to a lesser extent, lower foreign exchange transaction losses in the three months ended January 31, 2022.
33
INDEX

Below is a reconciliation of our US GAAP EPS to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below, are presented in the section above, “Provision for Income Taxes”.

|  | Three Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP EPS |  | $ | 0.63 |  |  | $ | 0.39 |
Adjustments: |  |  |  |  |  |  |  |
Restructuring and related charges |  |  | 0.01 |  |  |  | 0.28 |
Foreign exchange losses on intercompany transactions |  |  | 0.01 |  |  |  | 0.01 |
Amortization of acquired intangible assets |  |  | 0.30 |  |  |  | 0.27 |
Non-GAAP Adjusted EPS |  | $ | 0.95 |  |  | $ | 0.95 |

On a constant currency basis, Adjusted EPS decreased 9% primarily due to lower Adjusted CTP, partially offset by a lower Adjusted income tax provision.
SEGMENT OPERATING RESULTS

|  | Three Months Ended January 31, |  |  |  |  |  | Constant Currency |
RESEARCH PUBLISHING & PLATFORMS: |  | 2022 |  |  | 2021 |  |  | % Change Favorable (Unfavorable) |  |  | % Change Favorable (Unfavorable) |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing |  | $ | 248,884 |  |  | $ | 229,327 |  |  |  | 9 | % |  |  | 9 | %
Research Platforms |  |  | 14,457 |  |  |  | 10,523 |  |  |  | 37 | % |  |  | 37 | %
Total Research Publishing & Platforms Revenue |  |  | 263,341 |  |  |  | 239,850 |  |  |  | 10 | % |  |  | 10 | %
Cost of Sales |  |  | 72,037 |  |  |  | 66,883 |  |  |  | (8 | )% |  |  | (8 | )%
Operating Expenses |  |  | 117,160 |  |  |  | 102,628 |  |  |  | (14 | )% |  |  | (15 | )%
Amortization of Intangible Assets |  |  | 11,979 |  |  |  | 9,474 |  |  |  | (26 | )% |  |  | (27 | )%
Restructuring Charges (see Note 9) |  |  | — |  |  |  | 83 |  |  |  | 100 | % |  |  | 100 | %
Contribution to Profit |  |  | 62,165 |  |  |  | 60,782 |  |  |  | 2 | % |  |  | 1 | %
Restructuring Charges (see Note 9) |  |  | — |  |  |  | 83 |  |  |  | 100 | % |  |  | 100 | %
Adjusted Contribution to Profit |  |  | 62,165 |  |  |  | 60,865 |  |  |  | 2 | % |  |  | 1 | %
Depreciation and amortization |  |  | 23,914 |  |  |  | 20,997 |  |  |  | (14 | )% |  |  | (14 | )%
Adjusted EBITDA |  | $ | 86,079 |  |  | $ | 81,862 |  |  |  | 5 | % |  |  | 4 | %
Adjusted EBITDA Margin |  |  | 32.7 | % |  |  | 34.1 | % |  |  |  |  |  |  |  |

# Not meaningful
Revenue:
Research Publishing & Platforms revenue for the three months ended January 31, 2022 increased $23.5 million, or 10%, as compared with the prior year on a reported basis and on a constant currency basis. Excluding revenue from acquisitions, organic revenue increased 5% on a constant currency basis. This increase was primarily due to an increase in publishing, corporate solutions and, to a lesser extent Research Platforms. Research Publishing has continued growth due to Transitional Agreements (read and publish), sometimes referred to as Comprehensive Agreements. Excluding the impact from acquisitions, Open Access article output growth was approximately 16% for the three months ended January 31, 2022 as compared with the prior year.
Adjusted EBITDA:
On a constant currency basis, Adjusted EBITDA increased 4% as compared with the prior year. This increase was primarily due to higher revenue, partially offset by higher editorial costs due to additional resources to support investments in growth, which includes the impact of the acquisition of Hindawi and, to a lesser extent, higher cost of sales, which includes the incremental impact of acquisitions and technology-related costs.
34
INDEX

|  | Three Months Ended January 31, |  |  |  |  |  | Constant Currency |
ACADEMIC & PROFESSIONAL LEARNING: |  | 2022 |  |  | 2021 |  |  | % Change Favorable (Unfavorable) |  |  | % Change Favorable (Unfavorable) |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
Education Publishing (1) |  | $ | 95,498 |  |  | $ | 97,671 |  |  |  | (2 | )% |  |  | (2 | )%
Professional Learning |  |  | 75,135 |  |  |  | 75,955 |  |  |  | (1 | )% |  |  | — |
Total Academic & Professional Learning |  |  | 170,633 |  |  |  | 173,626 |  |  |  | (2 | )% |  |  | (1 | )%
Cost of Sales |  |  | 46,421 |  |  |  | 48,103 |  |  |  | 3 | % |  |  | 3 | %
Operating Expenses |  |  | 85,806 |  |  |  | 88,246 |  |  |  | 3 | % |  |  | 2 | %
Amortization of Intangible Assets |  |  | 3,417 |  |  |  | 4,126 |  |  |  | 17 | % |  |  | 16 | %
Restructuring Charges (see Note 9) |  |  | 215 |  |  |  | 328 |  |  |  | 34 | % |  |  | 34 | %
Contribution to Profit |  |  | 34,774 |  |  |  | 32,823 |  |  |  | 6 | % |  |  | 7 | %
Restructuring Charges (see Note 9) |  |  | 215 |  |  |  | 328 |  |  |  | 34 | % |  |  | 34 | %
Adjusted Contribution to Profit |  |  | 34,989 |  |  |  | 33,151 |  |  |  | 6 | % |  |  | 6 | %
Depreciation and amortization |  |  | 17,038 |  |  |  | 17,233 |  |  |  | 1 | % |  |  | — |
Adjusted EBITDA |  | $ | 52,027 |  |  | $ | 50,384 |  |  |  | 3 | % |  |  | 4 | %
Adjusted EBITDA Margin |  |  | 30.5 | % |  |  | 29.0 | % |  |  |  |  |  |  |  |

# Not meaningful

(1) | In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services - Talent Development Services. The Revenue, Adjusted Contribution to Profit and Adjusted EBITDA for WileyNXT was $0.5 million, $(0.2) million, and $(0.2) million, respectively, for the three months ended January 31, 2021. There were no changes to our total consolidated financial results.

Revenue:
Academic & Professional Learning revenue decreased $3.0 million, or 2%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 1% as compared with the prior year. The decrease in Education Publishing was due to lower US enrollment and an easing of the prior-year COVID-19 related favorability for courseware and content, and test preparation. Professional Learning was flat due to an increase in corporate training due to a strong recovery from prior year COVID-19 lockdown impacts, offset by a decrease in professional publishing.
Adjusted EBITDA:
On a constant currency basis, Adjusted EBITDA increased 4% as compared with the prior year. This increase was attributable to lower operating expenses, primarily due a decline in sales costs, which more than offset lower revenues.
35
INDEX

|  | Three Months Ended January 31, |  |  |  |  |  | Constant Currency |
EDUCATION SERVICES: |  | 2022 |  |  | 2021 |  |  | % Change Favorable (Unfavorable) |  |  | % Change Favorable (Unfavorable) |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
University Services (1) |  | $ | 55,090 |  |  | $ | 56,725 |  |  |  | (3 | )% |  |  | (3 | )%
Talent Development Services (2)(3) |  |  | 26,820 |  |  |  | 12,711 |  |  |  | # |  |  |  | # |
Total Education Services Revenue |  |  | 81,910 |  |  |  | 69,436 |  |  |  | 18 | % |  |  | 18 | %
Cost of Sales |  |  | 54,457 |  |  |  | 42,651 |  |  |  | (28 | )% |  |  | (28 | )%
Operating Expenses |  |  | 19,134 |  |  |  | 16,073 |  |  |  | (19 | )% |  |  | (19 | )%
Amortization of Intangible Assets |  |  | 5,660 |  |  |  | 5,431 |  |  |  | (4 | )% |  |  | (4 | )%
Restructuring Charges (see Note 9) |  |  | 5 |  |  |  | 71 |  |  |  | 93 | % |  |  | 93 | %
Contribution to Profit |  |  | 2,654 |  |  |  | 5,210 |  |  |  | (49 | )% |  |  | (49 | )%
Restructuring Charges (see Note 9) |  |  | 5 |  |  |  | 71 |  |  |  | 93 | % |  |  | 93 | %
Adjusted Contribution to Profit |  |  | 2,659 |  |  |  | 5,281 |  |  |  | (50 | )% |  |  | (49 | )%
Depreciation and amortization |  |  | 8,260 |  |  |  | 7,493 |  |  |  | (10 | )% |  |  | (10 | )%
Adjusted EBITDA |  | $ | 10,919 |  |  | $ | 12,774 |  |  |  | (15 | )% |  |  | (14 | )%
Adjusted EBITDA Margin |  |  | 13.3 | % |  |  | 18.4 | % |  |  |  |  |  |  |  |

# Not meaningful

(1) | University Services was previously referred to as Education Services OPM.

(2) | Talent Development Services was previously referred to as mthree.

(3) | In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services – Talent Development Services. The Revenue, Adjusted Contribution to Profit and Adjusted EBITDA for WileyNXT was $0.5 million, $(0.2) million, and $(0.2) million, respectively, for the three months ended January 31, 2021. There were no changes to our total consolidated financial results.

Revenue:
Education Services revenue increased $12.5 million, or 18%, as compared with the prior year on a reported basis and on a constant currency basis as compared with the prior year. Excluding revenue from acquisitions, organic revenue increased 17% on a constant currency basis. This increase was primarily due to an increase in placements in Talent Development Services, partially offset by a decline in University Services due to lower US student enrollment. We delivered approximately 140% growth in IT talent placements in Talent Development Services. University Services experienced a modest decrease in online enrollment.
Adjusted EBITDA:
On a constant currency basis, Adjusted EBITDA decreased 14% as compared with the prior year. This decrease was due to an increase in employee related costs due to increased investments to accelerate growth in Talent Development Services and, to a lesser extent, higher student acquisition costs in University Services, which more than offset higher revenues.
Education Services Partners and Programs:
As of January 31, 2022, Wiley had 64 full-service university partners under contract. As of January 31, 2021, Wiley had 69 university partners under contract.
CORPORATE EXPENSES:
Corporate expenses for the three months ended January 31, 2022 decreased $10.9 million, or 17%, as compared with the prior year. On a constant currency basis and excluding restructuring charges, these expenses increased 21% as compared with the prior year. This was primarily due to higher technology-related spending, increased marketing costs and, to a lesser extent, higher employee-related costs.
36
INDEX

RESULTS OF OPERATIONS – NINE MONTHS ENDED JANUARY 31, 2022
NINE MONTHS SUMMARY:

• | US GAAP Results: Consolidated Revenue of $1,537 million (+9%, compared with the prior year), Operating Income of $161 million (+20%, compared with the prior year), EPS of $1.86 (-2%, compared with the prior year), Net Cash Provided by Operating Activities of $158 million (+2%, compared with the prior year)

• | Adjusted Results (at constant currency compared with the prior year): Consolidated Revenue of $1,537 million (+8%, compared with the prior year), Adjusted EBITDA of $322 million (+4%, compared with the prior year), Adjusted EPS of $3.09 (+4%, compared with the prior year), and Free Cash Flow of $77 million (-3%, compared with the prior year)

CONSOLIDATED RESULTS OF OPERATIONS
Revenue:
Revenue for the nine months ended January 31, 2022 increased $132.0 million, or 9%, as compared with the prior year. On a constant currency basis, revenue increased 8% as compared with the prior year including contributions from acquisitions. Excluding the contributions from acquisitions, revenue increased in each of our segments and 5% overall on a constant currency basis.
See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.
Cost of Sales:
Cost of sales for the nine months ended January 31, 2022 increased $56.4 million, or 12%, as compared with the prior year. On a constant currency basis, cost of sales increased 11% as compared with the prior year. This increase was primarily due to higher employee costs and, to a lesser extent, higher student acquisition costs in Education Services, increased print product costs in Academic & Professional Learning and, to a lesser extent, higher royalty costs in Research Publishing & Platforms.
Operating and Administrative Expenses:
Operating and administrative expenses for the nine months ended January 31, 2022 increased $64.5 million, or 9%, as compared with the prior year. On a constant currency basis, operating and administrative expenses increased 8% as compared with the prior year primarily reflecting higher editorial costs due to additional resources to support investments in growth, technology costs to support growth initiatives and, to a lesser extent, higher advertising and marketing costs.
Restructuring and Related (Credits) Charges:
For the nine months ended January 31, 2022 and 2021, we recorded pretax restructuring credits of $1.2 million and charges of $24.8 million, respectively, primarily related to our Business Optimization Program. These (credits) charges are reflected in Restructuring and related charges (credits) in our Unaudited Condensed Consolidated Statements of Net Income. See Note 9, “Restructuring and Related Charges (Credits)” for more details on these credits and charges.
For the impact of our restructuring program on diluted earnings per share, see the section below, “Diluted Earnings per Share (EPS).”
Amortization of Intangible Assets:
Amortization of intangible assets was $63.7 million for the nine months ended January 31, 2022, an increase of $10.6 million, or 20%, as compared with the prior year. On a constant currency basis, amortization of intangible assets increased 19% as compared with the prior year primarily due to the intangible assets acquired as part of the Hindawi acquisition completed in fiscal year 2021 and, to a lesser extent, other acquisitions completed in fiscal year 2022. See Note 3, “Acquisitions” for more details on our acquisitions.
Operating Income, Adjusted Contribution to Profit (CTP) and Adjusted EBITDA:
Operating income for the nine months ended January 31, 2022 increased $26.6 million, or 20%, as compared with the prior year. On a constant currency basis, operating income increased 19% as compared with the prior year, primarily due to the increase in revenue and, to a lesser extent, lower restructuring charges, partially offset by an increase in operating and administrative expenses and cost of sales.
37
INDEX

Adjusted CTP on a constant currency basis and excluding restructuring (credits) charges was flat as compared with the prior year primarily due to higher revenue performance as described above, offset by an increase in cost of sales, operating and administrative expenses and, to a lesser extent, amortization of intangible assets.
Adjusted EBITDA on a constant currency basis and excluding restructuring (credits) charges, increased 4%, as compared with the prior year primarily due to revenue performance, partially offset by an increase in operating and administrative expenses, and cost of sales.
Adjusted CTP
Below is a reconciliation of our consolidated US GAAP Operating Income to Non-GAAP Adjusted CTP:

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP Operating Income |  | $ | 160,845 |  |  | $ | 134,271 |
Adjustments: |  |  |  |  |  |  |  |
Restructuring and related (credits) charges |  |  | (1,161 | ) |  |  | 24,813 |
Non-GAAP Adjusted CTP |  | $ | 159,684 |  |  | $ | 159,084 |

Adjusted EBITDA
Below is a reconciliation of our consolidated US GAAP Net Income to Non-GAAP EBITDA and Adjusted EBITDA:

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Net Income |  | $ | 105,163 |  |  | $ | 106,927 |
Interest expense |  |  | 14,739 |  |  |  | 13,928 |
Provision for income taxes |  |  | 52,673 |  |  |  | 18,712 |
Depreciation and amortization |  |  | 162,484 |  |  |  | 147,253 |
Non-GAAP EBITDA |  |  | 335,059 |  |  |  | 286,820 |
Restructuring and related (credits) charges |  |  | (1,161 | ) |  |  | 24,813 |
Foreign exchange transaction losses |  |  | 1,488 |  |  |  | 6,473 |
Gain on sale of certain assets |  |  | (3,694 | ) |  |  | — |
Other income, net |  |  | (9,524 | ) |  |  | (11,769 | )
Non-GAAP Adjusted EBITDA |  | $ | 322,168 |  |  | $ | 306,337 |

Interest Expense:
Interest expense for the nine months ended January 31, 2022 was $14.7 million compared with the prior year of $13.9 million. This increase was due to a higher average debt balance outstanding, which included borrowings for the funding of acquisitions, partially offset by a lower weighted average effective interest rate.
Foreign Exchange Transaction Losses:
Foreign exchange transaction losses were $1.5 million for the nine months ended January 31, 2022 and were primarily due to losses on our foreign currency denominated third-party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.
Foreign exchange transaction losses were $6.5 million for the nine months ended January 31, 2021. The losses were primarily due to the unfavorable impact of the changes in exchange rates primarily on US Dollar cash balances held in the UK to fund the acquisition of Hindawi.
38
INDEX

Gain on Sale of Certain Assets:
The gain on the sale of certain assets is due to the sale of our world languages product portfolio which was included in our Academic & Professional Learning segment and resulted in a pretax gain of approximately $3.7 million during the nine months ended January 31, 2022.
Provision for Income Taxes:
Below is a reconciliation of our US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes:

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP Income Before Taxes |  | $ | 157,836 |  |  | $ | 125,639 |
Pretax Impact of Adjustments: |  |  |  |  |  |  |  |
Restructuring and related (credits) charges |  |  | (1,161 | ) |  |  | 24,813 |
Foreign exchange losses (gains) on intercompany transactions |  |  | 494 |  |  |  | (1,071 | )
Amortization of acquired intangible assets |  |  | 67,081 |  |  |  | 56,693 |
Gain on sale of certain assets |  |  | (3,694 | ) |  |  | — |
Non-GAAP Adjusted Income Before Taxes |  | $ | 220,556 |  |  | $ | 206,074 |

Below is a reconciliation of our US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP Income Tax Provision |  | $ | 52,673 |  |  | $ | 18,712 |
Income Tax Impact of Adjustments (1): |  |  |  |  |  |  |  |
Restructuring and related (credits) charges |  |  | (118 | ) |  |  | 6,362 |
Foreign exchange losses (gains) on intercompany transactions |  |  | 258 |  |  |  | (403 | )
Amortization of acquired intangible assets |  |  | 15,097 |  |  |  | 13,324 |
Gain on sale of certain assets |  |  | (922 | ) |  |  | — |
Income Tax Adjustments: |  |  |  |  |  |  |  |
Impact of increase in UK statutory rate on deferred tax balances (2) |  |  | (20,726 | ) |  |  | (6,772 | )
Impact of US CARES Act (3) |  |  | — |  |  |  | 13,998 |
Non-GAAP Adjusted Income Tax Provision |  | $ | 46,262 |  |  | $ | 45,221 |
US GAAP Effective Tax Rate |  |  | 33.4 | % |  |  | 14.9 | %
Non-GAAP Adjusted Effective Tax Rate |  |  | 21.0 | % |  |  | 21.9 | %

(1) | For the nine months ended January 31, 2022 and 2021, substantially all of the tax impact was from deferred taxes.

(2) | These adjustments impacted deferred taxes in the nine months ended January 31, 2022 and 2021.

(3) | For the nine months ended January 31, 2021, the tax impact was $8.4 million from current taxes and $5.6 million from deferred taxes.

The US GAAP effective tax rate for the nine months ended January 31, 2022 was 33.4%, compared with 14.9% for the nine months ended January 31, 2021. The rate for the nine months ended January 31, 2022 was greater than the US statutory rate, as well as the rate for the nine months ended January 31, 2021 due to an increase in the UK statutory rate, resulting in a noncash deferred tax expense from the re-measurement of our applicable UK net deferred tax liabilities. The 6-percentage point increase in the UK statutory rate during the nine months ended January 31, 2022 was greater than the 2-percentage point increase during the nine months ended January 31, 2021. In addition, during the nine months ended January 31, 2021, as a result of the CARES Act and certain regulations issued in late July 2020, we carried back certain US NOLs to a year with a higher statutory rate, decreasing the rate for the nine months ended January 31, 2021.
39
INDEX

During the nine months ended January 31, 2022, the UK enacted legislation that increased its statutory rate from 19% to 25% effective April 1, 2023, resulting in a $20.7 million non-cash deferred tax expense. During the nine months ended January 31, 2021, the UK officially enacted legislation that increased its statutory rate from 17% to 19%, resulting in a $6.7 million non-cash deferred tax expense.
The Non-GAAP Adjusted effective tax rate for the nine months ended January 31, 2022 was 21.0%, compared with 21.9% for the nine months ended January 31, 2021. The rate for the nine months ended January 31, 2022, was slightly lower than the rate for the nine months ended January 31, 2021 primarily due to the mix of income at lower rates.
Diluted Earnings per Share (EPS):
EPS for the nine months ended January 31, 2022 was $1.86 per share compared with $1.90 per share for the nine months ended January 31, 2021. This decrease was due to a higher provision for income taxes driven by the CARES Act benefit of $0.25 per share in the nine months ended January 31, 2021, partially offset by higher operating income and, to a lesser extent, lower foreign exchange transaction losses, and the gain on sale of certain assets.
Below is a reconciliation of our US GAAP EPS to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below, are presented in the section above, “Provision for Income Taxes”.

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
US GAAP EPS |  | $ | 1.86 |  |  | $ | 1.90 |
Adjustments: |  |  |  |  |  |  |  |
Restructuring and related (credits) charges |  |  | (0.02 | ) |  |  | 0.33 |
Foreign exchange gains on intercompany transactions |  |  | — |  |  |  | (0.01 | )
Amortization of acquired intangible assets |  |  | 0.93 |  |  |  | 0.77 |
Gain on sale of certain assets |  |  | (0.05 | ) |  |  | — |
Income tax adjustments |  |  | 0.37 |  |  |  | (0.13 | )
Non-GAAP Adjusted EPS |  | $ | 3.09 |  |  | $ | 2.86 |

On a constant currency basis, Adjusted EPS increased 4% primarily due to an increase in Adjusted EBITDA and, to a lesser extent, lower foreign exchange transaction losses.
40
INDEX

SEGMENT OPERATING RESULTS

|  | Nine Months Ended January 31, |  |  |  |  |  | Constant Currency |
RESEARCH PUBLISHING & PLATFORMS: |  | 2022 |  |  | 2021 |  |  | % Change Favorable (Unfavorable) |  |  | % Change Favorable (Unfavorable) |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
Research Publishing |  | $ | 775,115 |  |  | $ | 700,482 |  |  |  | 11 | % |  |  | 9 | %
Research Platforms |  |  | 38,136 |  |  |  | 31,512 |  |  |  | 21 | % |  |  | 21 | %
Total Research Publishing & Platforms Revenue |  |  | 813,251 |  |  |  | 731,994 |  |  |  | 11 | % |  |  | 10 | %
Cost of Sales |  |  | 218,369 |  |  |  | 201,599 |  |  |  | (8 | )% |  |  | (6 | )%
Operating Expenses |  |  | 341,084 |  |  |  | 300,894 |  |  |  | (13 | )% |  |  | (12 | )%
Amortization of Intangible Assets |  |  | 35,556 |  |  |  | 25,165 |  |  |  | (41 | )% |  |  | (39 | )%
Restructuring Charges (Credits) (see Note 9) |  |  | 238 |  |  |  | (352 | ) |  |  | # |  |  |  | # |
Contribution to Profit |  |  | 218,004 |  |  |  | 204,688 |  |  |  | 7 | % |  |  | 6 | %
Restructuring Charges (Credits) (see Note 9) |  |  | 238 |  |  |  | (352 | ) |  |  | # |  |  |  | # |
Adjusted Contribution to Profit |  |  | 218,242 |  |  |  | 204,336 |  |  |  | 7 | % |  |  | 7 | %
Depreciation and amortization |  |  | 71,140 |  |  |  | 60,463 |  |  |  | (18 | )% |  |  | (16 | )%
Adjusted EBITDA |  | $ | 289,382 |  |  | $ | 264,799 |  |  |  | 9 | % |  |  | 9 | %
Adjusted EBITDA Margin |  |  | 35.6 | % |  |  | 36.2 | % |  |  |  |  |  |  |  |

# Not meaningful
Revenue:
Research Publishing & Platforms revenue for the nine months ended January 31, 2022 increased $81.3 million, or 11%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 10% as compared with the prior year. Excluding revenue from acquisitions, organic revenue increased 4% on a constant currency basis. This increase was primarily due to an increase in publishing, corporate solutions and, to a lesser extent an increase in Research Platforms. Research Publishing has continued growth due to Transitional Agreements (read and publish), sometimes referred to as Comprehensive Agreements. Excluding the impact from acquisitions, Open Access article output growth was approximately 25% for the nine months ended January 31, 2022 as compared with the prior year.
Adjusted EBITDA:
On a constant currency basis, Adjusted EBITDA increased 9% as compared with the prior year. This increase was primarily due to higher revenue, partially offset by higher editorial costs due to additional resources to support investments in growth, which includes the impact of the acquisition of Hindawi and, to a lesser extent, higher cost of sales including the incremental impact of acquisitions, technology, and sales-related costs.
41
INDEX

|  | Nine Months Ended January 31, |  |  |  |  |  | Constant Currency |
ACADEMIC & PROFESSIONAL LEARNING: |  | 2022 |  |  | 2021 |  |  | % Change Favorable (Unfavorable) |  |  | % Change Favorable (Unfavorable) |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
Education Publishing (1) |  | $ | 260,459 |  |  | $ | 263,702 |  |  |  | (1 | )% |  |  | (2 | )%
Professional Learning |  |  | 225,967 |  |  |  | 206,269 |  |  |  | 10 | % |  |  | 9 | %
Total Academic & Professional Learning |  |  | 486,426 |  |  |  | 469,971 |  |  |  | 4 | % |  |  | 3 | %
Cost of Sales |  |  | 134,334 |  |  |  | 129,700 |  |  |  | (4 | )% |  |  | (3 | )%
Operating Expenses |  |  | 257,524 |  |  |  | 263,441 |  |  |  | 2 | % |  |  | 3 | %
Amortization of Intangible Assets |  |  | 10,650 |  |  |  | 12,376 |  |  |  | 14 | % |  |  | 14 | %
Restructuring (Credits) Charges (see Note 9) |  |  | (79 | ) |  |  | 1,902 |  |  |  | # |  |  |  | # |
Contribution to Profit |  |  | 83,997 |  |  |  | 62,552 |  |  |  | 34 | % |  |  | 33 | %
Restructuring (Credits) Charges (see Note 9) |  |  | (79 | ) |  |  | 1,902 |  |  |  | # |  |  |  | # |
Adjusted Contribution to Profit |  |  | 83,918 |  |  |  | 64,454 |  |  |  | 30 | % |  |  | 29 | %
Depreciation and amortization |  |  | 53,550 |  |  |  | 53,757 |  |  |  | — |  |  |  | 1 | %
Adjusted EBITDA |  | $ | 137,468 |  |  | $ | 118,211 |  |  |  | 16 | % |  |  | 15 | %
Adjusted EBITDA Margin |  |  | 28.3 | % |  |  | 25.2 | % |  |  |  |  |  |  |  |

# Not meaningful

(1) | In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services – Talent Development Services. The Revenue, Adjusted Contribution to Profit and Adjusted EBITDA for WileyNXT was $1.6 million, $(0.4) million, and $(0.4) million, respectively, for the nine months ended January 31, 2021. There were no changes to our total consolidated financial results.

Revenue:
Academic & Professional Learning revenue increased $16.5 million, or 4%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 3% as compared with the prior year. This increase was primarily driven by strong recovery in Professional Learning from prior year COVID-19 lockdown impacts primarily due to an increase in corporate training, and an increase in professional publishing compared with the prior year. This more than offset a 2% decline in Education Publishing due to lower US college enrollment and some easing of prior year COVID-19 related favorability for courseware and content and, to a lesser extent, test preparation.
Adjusted EBITDA:
On a constant currency basis, Adjusted EBITDA increased 15% as compared with the prior year. This increase was due to higher revenues and, to a lesser extent, lower sales costs. This was partially offset by higher print product costs.
42
INDEX

|  | Nine Months Ended January 31, |  |  |  |  |  | Constant Currency |
EDUCATION SERVICES: |  | 2022 |  |  | 2021 |  |  | % Change Favorable (Unfavorable) |  |  | % Change Favorable (Unfavorable) |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
University Services (1) |  | $ | 167,565 |  |  | $ | 163,248 |  |  |  | 3 | % |  |  | 2 | %
Talent Development Services (2)(3) |  |  | 70,033 |  |  |  | 40,036 |  |  |  | 75 | % |  |  | 70 | %
Total Education Services Revenue |  |  | 237,598 |  |  |  | 203,284 |  |  |  | 17 | % |  |  | 16 | %
Cost of Sales |  |  | 160,950 |  |  |  | 126,001 |  |  |  | (28 | )% |  |  | (26 | )%
Operating Expenses |  |  | 57,646 |  |  |  | 48,480 |  |  |  | (19 | )% |  |  | (18 | )%
Amortization of Intangible Assets |  |  | 17,477 |  |  |  | 15,547 |  |  |  | (12 | )% |  |  | (12 | )%
Restructuring (Credits) Charges (see Note 9) |  |  | (23 | ) |  |  | 294 |  |  |  | # |  |  |  | # |
Contribution to Profit |  |  | 1,548 |  |  |  | 12,962 |  |  |  | (88 | )% |  |  | (89 | )%
Restructuring (Credits) Charges (see Note 9) |  |  | (23 | ) |  |  | 294 |  |  |  | # |  |  |  | # |
Adjusted Contribution to Profit |  |  | 1,525 |  |  |  | 13,256 |  |  |  | (88 | )% |  |  | (90 | )%
Depreciation and amortization |  |  | 25,376 |  |  |  | 21,982 |  |  |  | (15 | )% |  |  | (15 | )%
Adjusted EBITDA |  | $ | 26,901 |  |  | $ | 35,238 |  |  |  | (24 | )% |  |  | (24 | )%
Adjusted EBITDA Margin |  |  | 11.3 | % |  |  | 17.3 | % |  |  |  |  |  |  |  |

# Not meaningful

(1) | University Services was previously referred to as Education Services OPM.

(2) | Talent Development Services was previously referred to as mthree.

(3) | In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services – Talent Development Services. The Revenue, Adjusted Contribution to Profit and Adjusted EBITDA for WileyNXT was $1.6 million, $(0.4) million, and $(0.4) million, respectively, for the nine months ended January 31, 2021. There were no changes to our total consolidated financial results.

Revenue:
Education Services revenue increased $34.3 million, or 17%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 16% as compared with the prior year. Excluding revenue from acquisitions, organic revenue increased 15% on a constant currency basis. This increase was primarily due to an increase in placements in Talent Development Services and, to a lesser extent, higher student enrollments in University Services. For the nine months ended January 31, 2022, University Services experienced a 3% increase in online enrollment. For the nine months ended January 31, 2022, we delivered approximately 140% growth in IT talent placements in Talent Development Services.
Adjusted EBITDA:
On a constant currency basis, Adjusted EBITDA decreased 24% as compared with the prior year. This was due to an increase in employee related costs due to increased investments to accelerate growth in Talent Development Services and, to a lesser extent, higher student acquisition costs in University Services and sales related costs, partially offset by higher revenue.
CORPORATE EXPENSES:
Corporate expenses for the nine months ended January 31, 2022 decreased $3.2 million, or 2%, as compared with the prior year. On a constant currency basis and excluding restructuring (credits) charges, these expenses increased 17% as compared with the prior year. This was primarily due to higher employee-related costs, technology-related spending and marketing costs.
43
INDEX

FISCAL YEAR 2022 OUTLOOK:
Given performance through the nine months ended January 31, 2022 and leading indicators, the Company is reaffirming its Fiscal Year 2022 guidance ranges. As previously disclosed, we have added the newly defined Adjusted EPS metric described below. Going forward, Wiley will discontinue reporting on the former Adjusted EPS metric.
Amounts in millions, except Adjusted EPS

Metric | Fiscal Year 2020 Actual | Fiscal Year 2021 Actual | Fiscal Year 2022 Outlook
Revenue | $1,831 | $1,942 | $2,070 to $2,100
Adjusted EBITDA | $356 | $419 | $415 to $435
Adjusted EPS - newly defined | $3.30 | $4.00 | $4.00 to $4.25
Free Cash Flow | $173 | $257 | $200 to $220

| ● | Revenue Outlook: Wiley expects consolidated revenue growth of mid-to-high single digits, to a range of $2.07 billion to $2.1 billion.

| ● | Adjusted EBITDA Outlook: Wiley expects a range between $415 and $435 million, with profit gains on higher revenue tempered by investments to drive profitable growth in Research and Education Services.

| ● | Adjusted EPS Outlook (newly defined): Wiley expects a range between $4.00 to $4.25.

| ● | Free Cash Flow Outlook: Wiley expects a range between $200 and $220 million. Higher cash earnings are expected to be partially offset by higher capital expenditures, higher net cash taxes due to the CARES Act related tax refund received in Fiscal Year 2021, and higher annual incentive compensation payments related to Fiscal Year 2021 outperformance, which were issued in the three months ended July 31, 2021.

| ● | Revenue and Adjusted EPS are trending toward the lower end of the guidance range due to the aforementioned market conditions in University Services and Education Publishing.

Adjusted EPS Change:
Going forward, Wiley’s Adjusted EPS metric will exclude the impact of certain non-cash items directly related to acquisitions, most notably the amortization of acquired intangible assets. The Company does not consider these non-cash items to be indicative of its ongoing operating performance. The amortization of intangible assets is reflected in Amortization of intangible assets on the Unaudited Condensed Consolidated Statements of Net Income. It also includes the amortization of acquired product development assets, which is reflected in Cost of sales in the Unaudited Condensed Consolidated Statements of Net Income. Under the new measurement, Adjusted EPS (excluding the impact of amortization of acquired intangible assets) was $0.95 for both the three months ended January 31, 2022 and 2021. For the nine months ended January 31, 2022, under the new measurement, Adjusted EPS (excluding the impact of amortization of acquired intangible assets) was $3.09 compared to $2.86 in the nine months ended January 31, 2021. See the reconciliation tables below for more information.
44
INDEX

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |  |  | Fiscal Year |  |  | Fiscal Year |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |  |  | 2021 |  |  | 2020 |
US GAAP Earnings (Loss) Per Share |  | $ | 0.63 |  |  | $ | 0.39 |  |  | $ | 1.86 |  |  | $ | 1.90 |  |  | $ | 2.63 |  |  | $ | (1.32 | )
Adjustments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring and related charges (credits) |  |  | 0.01 |  |  |  | 0.28 |  |  |  | (0.02 | ) |  |  | 0.33 |  |  |  | 0.44 |  |  |  | 0.43 |
Foreign exchange losses (gains) on intercompany transactions |  |  | 0.01 |  |  |  | 0.01 |  |  |  | — |  |  |  | (0.01 | ) |  |  | (0.02 | ) |  |  | 0.02 |
Gain on sale of certain assets |  |  | — |  |  |  | — |  |  |  | (0.05 | ) |  |  | — |  |  |  | — |  |  |  | — |
Income tax adjustments |  |  | — |  |  |  | — |  |  |  | 0.37 |  |  |  | (0.13 | ) |  |  | (0.13 | ) |  |  | (0.03 | )
Impairment of goodwill |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1.94 |
Impairment of Blackwell trade name |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1.31 |
Impairment of developed technology intangible |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 0.04 |
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 0.01 |
Non-GAAP Adjusted EPS (Previously Reported) |  | $ | 0.65 |  |  | $ | 0.68 |  |  | $ | 2.16 |  |  | $ | 2.09 |  |  | $ | 2.92 |  |  | $ | 2.40 |
Amortization of acquired intangible assets |  |  | 0.30 |  |  |  | 0.27 |  |  |  | 0.93 |  |  |  | 0.77 |  |  |  | 1.08 |  |  |  | 0.90 |
Non-GAAP Adjusted EPS (Newly Defined) |  | $ | 0.95 |  |  | $ | 0.95 |  |  | $ | 3.09 |  |  | $ | 2.86 |  |  | $ | 4.00 |  |  | $ | 3.30 |
Weighted average number of common shares outstanding: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diluted (shares in 000's) (1) |  |  | 56,389 |  |  |  | 56,332 |  |  |  | 56,481 |  |  |  | 56,230 |  |  |  | 56,461 |  |  |  | 56,729 |

(1) | For Fiscal Year 2020, represents the impact of using diluted weighted-average number of common shares outstanding (56.7 million shares for the year ended April 30, 2020) included in the Non-US GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

Below is a reconciliation of our US GAAP Income (Loss) Before Taxes to Non-GAAP Adjusted Income Before Taxes:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |  |  | Fiscal Year |  |  | Fiscal Year |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |  |  | 2021 |  |  | 2020 |
US GAAP Income (Loss) Before Taxes |  | $ | 43,219 |  |  | $ | 27,392 |  |  | $ | 157,836 |  |  | $ | 125,639 |  |  | $ | 175,912 |  |  | $ | (63,092 | )
Pretax Impact of Adjustments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring and related charges (credits) |  |  | 448 |  |  |  | 20,675 |  |  |  | (1,161 | ) |  |  | 24,813 |  |  |  | 33,310 |  |  |  | 32,607 |
Foreign exchange losses (gains) on intercompany transactions |  |  | 722 |  |  |  | 267 |  |  |  | 494 |  |  |  | (1,071 | ) |  |  | (1,457 | ) |  |  | 1,256 |
Gain on sale of certain assets |  |  | — |  |  |  | — |  |  |  | (3,694 | ) |  |  | — |  |  |  | — |  |  |  | — |
Impairment of goodwill |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 110,000 |
Impairment of Blackwell trade name |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 89,507 |
Impairment of developed technology intangible |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,841 |
Non-GAAP Adjusted Income Before Taxes (Previously Reported) |  | $ | 44,389 |  |  | $ | 48,334 |  |  | $ | 153,475 |  |  | $ | 149,381 |  |  | $ | 207,765 |  |  | $ | 173,119 |
Amortization of acquired intangible assets |  |  | 22,189 |  |  |  | 20,163 |  |  |  | 67,081 |  |  |  | 56,693 |  |  |  | 79,421 |  |  |  | 68,269 |
Non-GAAP Adjusted Income Before Taxes (Newly Defined) |  | $ | 66,578 |  |  | $ | 68,497 |  |  | $ | 220,556 |  |  | $ | 206,074 |  |  | $ | 287,186 |  |  | $ | 241,388 |

45
INDEX

Below is a reconciliation of our US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

|  | Three Months Ended January 31, |  |  | Nine Months Ended January 31, |  |  | Fiscal Year |  |  | Fiscal Year |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |  |  | 2021 |  |  | 2020 |
US GAAP Income Tax Provision |  | $ | 7,853 |  |  | $ | 5,231 |  |  | $ | 52,673 |  |  | $ | 18,712 |  |  | $ | 27,656 |  |  | $ | 11,195 |
Income Tax Impact of Adjustments (1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring and related charges (credits) |  |  | 114 |  |  |  | 4,965 |  |  |  | (118 | ) |  |  | 6,362 |  |  |  | 8,065 |  |  |  | 7,949 |
Foreign exchange losses (gains) on intercompany transactions |  |  | 239 |  |  |  | 87 |  |  |  | 258 |  |  |  | (403 | ) |  |  | (363 | ) |  |  | 242 |
Gain on sale of certain assets |  |  | — |  |  |  | — |  |  |  | (922 | ) |  |  | — |  |  |  | — |  |  |  | — |
Impairment of Blackwell trade name |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 15,216 |
Impairment of developed technology intangible |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 686 |
Income Tax Adjustments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Impact of increase in UK statutory rate on deferred tax balances (2) |  |  | — |  |  |  | — |  |  |  | (20,726 | ) |  |  | (6,772 | ) |  |  | (3,511 | ) |  |  | — |
Impact of US CARES Act (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 13,998 |  |  |  | 13,998 |  |  |  | — |
Impact of change in certain US state tax rates in 2021 and tax rates in France in 2020 (2) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (3,225 | ) |  |  | 1,887 |
Non-GAAP Adjusted Income Tax Provision (Previously Reported) |  | $ | 8,206 |  |  | $ | 10,283 |  |  | $ | 31,165 |  |  | $ | 31,897 |  |  | $ | 42,620 |  |  | $ | 37,175 |
Amortization of acquired intangible assets (1) |  |  | 4,834 |  |  |  | 4,691 |  |  |  | 15,097 |  |  |  | 13,324 |  |  |  | 18,511 |  |  |  | 16,820 |
Non-GAAP Adjusted Income Tax Provision (Newly Defined) |  | $ | 13,040 |  |  | $ | 14,974 |  |  | $ | 46,262 |  |  | $ | 45,221 |  |  | $ | 61,131 |  |  | $ | 53,995 |
US GAAP Effective Tax Rate |  |  | 18.2 | % |  |  | 19.1 | % |  |  | 33.4 | % |  |  | 14.9 | % |  |  | 15.7 | % |  |  | (17.7 | )%
Non-GAAP Adjusted Effective Tax Rate (Previously Reported) |  |  | 18.5 | % |  |  | 21.3 | % |  |  | 20.3 | % |  |  | 21.4 | % |  |  | 20.5 | % |  |  | 21.5 | %
Non-GAAP Adjusted Effective Tax Rate (Newly Defined) |  |  | 19.6 | % |  |  | 21.9 | % |  |  | 21.0 | % |  |  | 21.9 | % |  |  | 21.3 | % |  |  | 22.4 | %

(1) | These adjustments substantially impacted deferred taxes.

(2) | These adjustments impacted deferred taxes.

(3) | The tax impact was $8.4 million from current taxes and $5.6 million from deferred taxes.

Below is a reconciliation of our consolidated US GAAP Net Income to Non-GAAP EBITDA and Adjusted EBITDA for the year ended April 30, 2021:

|  | Fiscal Year |
|  | 2021 |
Net Income |  | $ | 148,256 |
Interest expense |  |  | 18,383 |
Provision for income taxes |  |  | 27,656 |
Depreciation and amortization |  |  | 200,189 |
Non-GAAP EBITDA |  |  | 394,484 |
Restructuring and related charges |  |  | 33,310 |
Foreign exchange transaction losses |  |  | 7,977 |
Other income, net |  |  | (16,761 | )
Non-GAAP Adjusted EBITDA |  | $ | 419,010 |

46
INDEX

Below are the details of Free Cash Flow Less Product Development Spending for the year ended April 30, 2021:

|  | Fiscal Year |
|  | 2021 |
Net cash provided by operating activities |  | $ | 359,923 |
Less: Additions to technology, property and equipment |  |  | (77,407 | )
Less: Product development spending |  |  | (25,954 | )
Free cash flow less product development spending |  | $ | 256,562 |

LIQUIDITY AND CAPITAL RESOURCES
Principal Sources of Liquidity
We believe that our operating cash flow, together with our revolving credit facilities and other available debt financing, will be adequate to meet our operating, investing and financing needs in the foreseeable future. There can be no assurance that continued or increased volatility in the global capital and credit markets will not impair our ability to access these markets on terms commercially acceptable in the future. In addition, our liquidity could be adversely impacted by COVID-19 due to the continued impact on our customers, including cash collections. We do not have any off-balance-sheet debt. We will continue to pursue attractive opportunities to add scale and provide enhanced tech-enabled services in research and online education.
As of January 31, 2022, we had cash and cash equivalents of $109.4 million, of which approximately $101.5 million, or 93%, was located outside the US. Maintenance of these cash and cash equivalent balances outside the US does not have a material impact on the liquidity or capital resources of our operations. Notwithstanding the Tax Cuts and Jobs Act of 2017 (the Tax Act), which generally eliminated federal income tax on future cash repatriation to the US, cash repatriation may be subject to state and local taxes or withholding or similar taxes. Since April 30, 2018, we no longer intend to permanently reinvest earnings outside the US. We have a $2.5 million liability related to the estimated taxes that would be incurred upon repatriating certain non-US earnings.
On May 30, 2019, we entered into a credit agreement that amended and restated our existing revolving credit agreement, which was then amended on December 22, 2021 (collectively, the Amended and Restated RCA). See Note 15, “Debt and Available Credit Facilities” for more details on the amendment. The Amended and Restated RCA provides for senior unsecured credit facilities comprised of a (i) five-year revolving credit facility in an aggregate principal amount up to $1.25 billion, and (ii) a five-year term loan A facility consisting of $250 million. The agreement contains certain customary affirmative and negative covenants, including a financial covenant in the form of a consolidated net leverage ratio and consolidated interest coverage ratio.
As of January 31, 2022, we had approximately $917.7 million of debt outstanding, net of unamortized issuance costs of $0.4 million, and approximately $559.5 million of unused borrowing capacity under our Amended and Restated RCA and other facilities. Our Amended and Restated RCA contains certain restrictive covenants related to our consolidated leverage ratio and interest coverage ratio, which we were in compliance with as of January 31, 2022.
Analysis of Historical Cash Flows
The following table shows the changes in our Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended January 31, 2022 and 2021.

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Net cash provided by operating activities |  | $ | 158,484 |  |  | $ | 154,826 |
Net cash used in investing activities |  |  | (152,051 | ) |  |  | (392,393 | )
Net cash provided by financing activities |  |  | 13,099 |  |  |  | 115,843 |
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash |  | $ | (3,875 | ) |  | $ | 10,631 |

Cash flow from operations is seasonally a use of cash in the first half of Wiley’s fiscal year principally due to the timing of collections for annual journal subscriptions, which typically occurs in the beginning of the second half of our fiscal year.
47
INDEX

Free cash flow less product development spending helps assess our ability, over the long term, to create value for our shareholders, as it represents cash available to repay debt, pay common dividends, and fund share repurchases, and acquisitions. Below are the details of Free cash flow less product development spending.
Free Cash Flow less Product Development Spending:

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Net cash provided by operating activities |  | $ | 158,484 |  |  | $ | 154,826 |
Less: Additions to technology, property and equipment |  |  | (60,668 | ) |  |  | (58,176 | )
Less: Product development spending |  |  | (20,388 | ) |  |  | (17,103 | )
Free cash flow less product development spending |  | $ | 77,428 |  |  | $ | 79,547 |

Net Cash Provided By Operating Activities
The following is a summary of the $3.7 million change in Net cash provided by operating activities for the nine months ended January 31, 2022 compared with the nine months ended January 31, 2021 (amounts in millions).

Net cash provided by operating activities – Nine months ended January 31, 2021 |  | $ | 154.8 |
Net income adjusted for items to reconcile net income to net cash provided by operating activities, which would include such noncash items as, depreciation and amortization, and the change in deferred taxes |  |  | (1.6 | )
Working capital changes: |  |  |  |
Income taxes receivable and payable |  |  | 32.1 |
Accounts payable and accrued royalties |  |  | 26.7 |
Accounts receivable, net and contract liabilities |  |  | (29.2 | )
Changes in other assets and liabilities |  |  | (24.3 | )
Net cash provided by operating activities – Nine months ended January 31, 2022 |  | $ | 158.5 |

The change in income taxes was due to a $20.7 million receivable we recorded in the nine months ended January 31, 2021 in connection with the impact of the CARES Act, see Note 13, “Income taxes” which was received in February 2021 and, to a lesser extent, lower international tax payments in prior years, and timing in the nine months ended January 31, 2022.
The favorable change in accounts payable and accrued royalties was due to the timing of payments.
The unfavorable change in accounts receivable, net and contract liabilities was primarily the timing of billings and collections with customers, partially offset by sales growth.
The unfavorable changes in other assets and liabilities noted in the table above was primarily due to an increase in employee related costs, including payments due to higher annual incentive compensation payments in fiscal year 2022, partially offset by a decrease in restructuring payments, and the timing of prepayments.
Our negative working capital (current assets less current liabilities) was $329.9 million and $462.7 million as of January 31, 2022 and April 30, 2021, respectively. This $132.8 million change in negative working capital was primarily due to the seasonality of our business. The primary driver of the negative working capital is the benefit realized from unearned contract liabilities related to subscriptions for which cash has been collected in advance. The contract liabilities will be recognized as income when the products are shipped or made available online to the customers over the term of the subscription. Current liabilities as of January 31, 2022 and as of April 30, 2021 includes $355.8 million and $545.4 million, respectively, primarily related to deferred subscription revenue for which cash was collected in advance.
Cash collected in advance for subscriptions is used by us for a number of purposes including funding: operations, capital expenditures, acquisitions, debt repayments, dividend payments, and share repurchases. Many of our customers have been adversely impacted by COVID-19, and we expect some continued delays in payments due to widespread disruption and pervasive cash conservation behaviors in the face of uncertainty. We have recorded provisions for bad debt where appropriate.
48
INDEX

Net Cash Used In Investing Activities
Net cash used in investing activities for the nine months ended January 31, 2022 was $152.1 million compared to $392.4 million in the prior year. The decrease in cash used in investing activities was due to a decrease of $228.0 million in cash used to acquire businesses. See Note 3, “Acquisitions” for more information related to the acquisitions that occurred in the nine months ended January 31, 2022 and 2021. Additionally, cash outflows for the acquisitions of publication rights and other activities decreased $14.8 million.
Net Cash Provided By Financing Activities
Net cash provided by financing activities was $13.1 million for the nine months ended January 31, 2022 compared to $115.8 million for the nine months ended January 31, 2021. This decrease in cash provided by financing activities was primarily due to a decrease in net borrowings of long-term debt of $68.8 million, partially offset by an increase of $17.8 million in cash used for purchases of treasury shares, and $11.9 million change from book overdrafts.
Dividends and Share Repurchases
In June 2021, Wiley increased its quarterly dividend to shareholders to $1.38 per share annualized versus $1.37 per share annualized.
The following table summarizes the shares repurchased of Class A and Class B Common Stock for the nine months ended January 31, 2022 and 2021 (shares in thousands):

|  | Nine Months Ended January 31, |
|  | 2022 |  |  | 2021 |
Shares repurchased – Class A |  |  | 446 |  |  |  | 146 |
Shares repurchased – Class B |  |  | 2 |  |  |  | 1 |
Average price – Class A and Class B |  | $ | 55.48 |  |  | $ | 48.09 |

.
49
INDEX

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk primarily related to interest rates, foreign exchange, and credit risk. It is our policy to monitor these exposures and to use derivative financial investments and/or insurance contracts from time to time to reduce fluctuations in earnings and cash flows when it is deemed appropriate to do so. We do not use derivative financial instruments for trading or speculative purposes.
Interest Rates
From time to time, we may use interest rate swaps, collars, or options to manage our exposure to fluctuations in interest rates. It is management’s intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.
The information set forth in Note 16, "Derivatives Instruments and Hedging Activities," of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption "Interest Rate Contracts," is incorporated herein by reference.
On an annual basis, a hypothetical one percent change in interest rates for the $518.1 million of unhedged variable rate debt as of January 31, 2022 would affect net income and cash flow by approximately $4.1 million.
Foreign Exchange Rates
Fluctuations in the currencies of countries where we operate outside the US may have a significant impact on financial results. We are primarily exposed to movements in British pound sterling, euros, Canadian and Australian dollars, and certain currencies in Asia. The statements of financial position of non-US business units are translated into US dollars using period-end exchange rates for assets and liabilities and the statements of income are translated into US dollars using weighted-average exchange rates for revenues and expenses.
Our significant investments in non-US businesses are exposed to foreign currency risk. Adjustments resulting from translating assets and liabilities are reported as a separate component of Accumulated other comprehensive loss, net of tax within Shareholders’ Equity under the caption Foreign currency translation adjustment. During the three and nine months ended January 31, 2022, we recorded foreign currency translation losses in Accumulated other comprehensive loss, net of tax of approximately $15.9 million and $31.3 million, respectively, primarily as a result of the fluctuations of the US dollar relative to the euro and the British pound sterling. During the three and nine months ended January 31, 2021, we recorded foreign currency translation gains in Accumulated other comprehensive income, net of tax of approximately $48.3 million and $83.5 million, respectively, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling, and to a lesser extent the euro.
Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on the Unaudited Condensed Consolidated Statements of Net Income as incurred. Under certain circumstances, we may enter into derivative financial instruments in the form of foreign currency forward contracts to hedge against specific transactions, including intercompany purchases and loans.
The information set forth in Note 16, "Derivatives Instruments and Hedging Activities," of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption "Foreign Currency Contracts," is incorporated herein by reference.
Sales Return Reserves
The estimated allowance for print book sales returns is based upon historical return patterns, as well as current market trends in the businesses in which we operate, including the impact of COVID-19. In connection with the estimated sales return reserves, we also include a related increase to inventory and a reduction to accrued royalties as a result of the expected returns.
The reserves are reflected in the following accounts of our Unaudited Condensed Consolidated Statements of Financial Position:

|  | January 31, 2022 |  |  | April 30, 2021 |
Increase in Inventories, net |  | $ | 10,243 |  |  | $ | 10,886 |
Decrease in Accrued royalties |  | $ | (4,971 | ) |  | $ | (4,949 | )
Increase in Contract liabilities |  | $ | 39,427 |  |  | $ | 38,034 |
Print book sales return reserve net liability balance |  | $ | (24,213 | ) |  | $ | (22,199 | )

50
INDEX

A one percent change in the estimated sales return rate could affect net income by approximately $1.4 million. A change in the pattern or trends in returns could affect the estimated allowance.
Customer Credit Risk
In the journal publishing business, subscriptions are primarily sourced through journal subscription agents who, acting as agents for library customers, facilitate ordering by consolidating the subscription orders/billings of each subscriber with various publishers. Cash is generally collected in advance from subscribers by the subscription agents and is principally remitted to us between the months of December and April. Although currently we have minimal credit risk exposure to these agents, future calendar-year subscription receipts from these agents are highly dependent on their financial condition and liquidity. Subscription agents account for approximately 20% of total annual consolidated revenue, and no one affiliated group of subscription agents accounts for more than 10% of total annual consolidated revenue.
Our book business is not dependent upon a single customer; however, the industry is concentrated in national, regional, and online bookstore chains. No single book customer accounts for more than 8% of total consolidated revenue and more than 17% of accounts receivable at January 31, 2022. The top 10 book customers account for approximately 13% of total consolidated revenue and approximately 28% of accounts receivable at January 31, 2022.
Many of our customers have been adversely impacted by COVID-19, and we expect some continued delays in payments due to widespread disruption and pervasive cash conservation behaviors in the face of uncertainty.
ITEM 4. CONTROLS AND PROCEDURES
The Company's Chief Executive Officer and Chief Financial Officer, together with the Chief Accounting Officer and other members of the Company's management, have conducted an evaluation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting: During the three months ended January 31, 2022, we closed on the acquisition of XYZ Media Inc. (XYZ Media). We excluded XYZ Media from the scope of management’s report on internal control over financial reporting for the nine months ended January 31, 2022. We are in the process of integrating XYZ Media to our overall internal control over financial reporting and will include them in scope for the year ending April 30, 2022. This process may result in additions or changes to our internal control over financial reporting.
We continue to implement additional functionality and enhancements to our previously disclosed global ERP implementation. As with any new information system we implement, this application, along with the internal controls over financial reporting included in this process, will require testing for effectiveness. In connection with this ERP implementation, we are updating our internal controls over financial reporting, as necessary, to accommodate modifications to our business processes and accounting procedures. We do not believe that the ERP implementation will have an adverse effect on our internal control over financial reporting.
Except as described above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) during the quarter ended January 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
51
INDEX

PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
There have been no significant developments related to legal proceedings during the three months ended January 31, 2022. For information regarding legal proceedings, see our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 Note 16, “Commitment and Contingencies”.
ITEM 1A. RISK FACTORS
See Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended April 30, 2021. Except as required by the federal securities law, we undertake no obligation to update or revise any risk factor, whether as a result of new information, future events or otherwise.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During the three months ended January 31, 2022, we made the following purchases of Class A and Class B Common Stock under our publicly announced stock repurchase programs:

|  | Total Number of Shares Purchased |  |  | Average Price Paid Per Share |  |  | Total Number of Shares Purchased as part of a Publicly Announced Program |  |  | Maximum Number of Shares that May be Purchased Under the Program |  |  | Maximum Dollar Value of Shares that May be Purchased Under Additional Plans or Programs (Dollars in millions) |
November 2021 |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | 184,328 |  |  | $ | 200 |
December 2021 |  |  | 84,810 |  |  |  | 54.66 |  |  |  | 84,810 |  |  |  | 99,518 |  |  |  | 200 |
January 2022 |  |  | 50,568 |  |  |  | 56.64 |  |  |  | 50,568 |  |  |  | 48,950 |  |  |  | 200 |
Total |  |  | 135,378 |  |  | $ | 55.40 |  |  |  | 135,378 |  |  |  | 48,950 |  |  | $ | 200 |

52
INDEX

ITEM 6. EXHIBITS

Material Contracts
10.1 | First Amendment to the Third Amended and Restated Credit Agreement (incorporated by reference to the Company’s Report on Form 8-K dated as of December 23, 2021).
10.2* | Amendment to the Deferred Compensation Plan for Directors' 2005 & After Compensation effective December 15, 2021.
10.3* | Amendment to the John Wiley & Sons, Inc. Employees' Savings Plan effective January 1, 2022.
10.4* | Amendment to the Deferred Compensation Plan effective January 1, 2022.
Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.1* | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.1* | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2* | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Inline XBRL
101.INS* | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH* | Inline XBRL Taxonomy Extension Schema Document.
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Filed herewith
53
INDEX

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | JOHN WILEY & SONS, INC. |
|  | Registrant |
| By | /s/ Brian A. Napack |
|  | Brian A. Napack |
|  | President and Chief Executive Officer |
| By | /s/ Christina Van Tassell |
|  | Christina Van Tassell |
|  | Executive Vice President and Chief Financial Officer |
| By | /s/ Christopher F. Caridi |
|  | Christopher F. Caridi |
|  | Senior Vice President, Global Corporate Controller and Chief Accounting Officer |
|  | Dated: March 9, 2022 |

54
INDEX